TAL1	B-protein
and	O
LIM-only	B-protein
proteins	I-protein
synergistically	O
induce	O
retinaldehyde	B-protein
dehydrogenase	I-protein
2	I-protein
expression	O
in	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
by	O
acting	O
as	O
cofactors	O
for	O
GATA3	B-protein
.	O

Previously	O
,	O
we	O
have	O
shown	O
that	O
TAL1	B-protein
and	O
the	O
LIM-only	B-DNA
protein	I-DNA
gene	I-DNA
(	O
LMO	B-DNA
)	O
are	O
regularly	O
coactivated	O
in	O
T-cell	O
acute	O
lymphoblastic	O
leukemia	O
(	O
T-ALL	O
)	O
.	O

This	O
observation	O
is	O
likely	O
to	O
relate	O
to	O
the	O
findings	O
that	O
TAL1	B-protein
and	O
LMO	B-protein
are	O
highly	O
synergistic	O
in	O
T-cell	O
tumorigenesis	O
in	O
double-transgenic	O
mice	O
.	O

To	O
understand	O
the	O
molecular	O
mechanisms	O
of	O
functional	O
synergy	O
between	O
TAL1	B-protein
and	O
LMO	B-protein
in	O
tumorigenesis	O
and	O
transcriptional	O
regulation	O
,	O
we	O
tried	O
to	O
identify	O
downstream	B-DNA
target	I-DNA
genes	I-DNA
regulated	O
by	O
TAL1	B-protein
and	O
LMO	B-protein
by	O
a	O
subtractive	O
PCR	O
method	O
.	O

One	O
of	O
the	O
isolated	O
genes	O
,	O
that	O
for	O
retinaldehyde	B-protein
dehydrogenase	I-protein
2	I-protein
(	O
RALDH2	B-protein
)	O
,	O
was	O
regularly	O
expressed	O
in	O
most	O
of	O
the	O
T-ALL	B-cell_line
cell	I-cell_line
lines	I-cell_line
that	O
coexpressed	O
TAL1	B-protein
and	O
LMO	B-protein
.	O

Exogenously	O
transfected	O
TAL1	B-protein
and	O
LMO	B-protein
,	O
but	O
not	O
either	O
alone	O
,	O
induced	O
RALDH2	B-protein
expression	O
in	O
a	O
T-ALL	B-cell_line
cell	I-cell_line
line	I-cell_line
,	O
HPB-ALL	B-cell_line
,	O
not	O
expressing	O
endogeneous	O
TAL1	B-protein
or	O
LMO	B-protein
.	O

The	O
RALDH2	B-RNA
transcripts	I-RNA
in	O
T-ALL	O
were	O
,	O
however	O
,	O
mostly	O
initiated	O
within	O
the	O
second	B-RNA
intron	I-RNA
.	O

Promoter	O
analysis	O
revealed	O
that	O
a	O
GATA	B-DNA
site	I-DNA
in	O
a	O
cryptic	B-DNA
promoter	I-DNA
in	O
the	O
second	B-DNA
intron	I-DNA
was	O
essential	O
and	O
sufficient	O
for	O
the	O
TAL1-	O
and	O
LMO-dependent	O
transcriptional	O
activation	O
,	O
and	O
GATA3	B-protein
binds	O
to	O
this	O
site	O
.	O

In	O
addition	O
,	O
forced	O
expression	O
of	O
GATA3	B-protein
potentiated	O
the	O
induction	O
of	O
RALDH2	B-protein
by	O
TAL1	B-protein
and	O
LMO	B-protein
,	O
and	O
these	O
three	O
factors	O
formed	O
a	O
complex	O
in	O
vivo	O
.	O

Furthermore	O
,	O
a	O
TAL1	B-protein
mutant	O
not	O
binding	O
to	O
DNA	O
also	O
activated	O
the	O
transcription	O
of	O
RALDH2	B-protein
in	O
the	O
presence	O
of	O
LMO	B-protein
and	O
GATA3	B-protein
.	O

Collectively	O
,	O
we	O
have	O
identified	O
the	O
RALDH2	B-DNA
gene	I-DNA
as	O
a	O
first	O
example	O
of	O
direct	O
transcriptional	B-DNA
target	I-DNA
genes	I-DNA
regulated	O
by	O
TAL1	B-protein
and	O
LMO	B-protein
in	O
T-ALL	O
.	O

In	O
this	O
case	O
,	O
TAL1	B-protein
and	O
LMO	B-protein
act	O
as	O
cofactors	O
for	O
GATA3	B-protein
to	O
activate	O
the	O
transcription	O
of	O
RALDH2	B-protein

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Dec.	NULL
1998	NULL
,	NULL
p.	NULL
6939-6950	NULL
0270-7306/98/	NULL
$	NULL
04.00+0	NULL
Vol	NULL
.	NULL

18	NULL
,	NULL
No	NULL
.	NULL

12	NULL
Copyright	NULL
©	NULL
1998	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
.	NULL

All	NULL
Rights	NULL
Reserved	NULL
.	NULL

TAL1	NULL
and	NULL
LIM-Only	NULL
Proteins	NULL
Synergistically	NULL
Induce	NULL
Retinaldehyde	NULL
Dehydrogenase	NULL
2	NULL
Expression	NULL
in	NULL
T-Cell	NULL
Acute	NULL
Lymphoblastic	NULL
Leukemia	NULL
by	NULL
Acting	NULL
as	NULL
Cofactors	NULL
for	NULL
GATA3	NULL
YUICHI	NULL
ONO	NULL
,	NULL
``	NULL
NORIO	NULL
anp	NULL
OSAMU	NULL
YOSHIE*	NULL
``	NULL
*	NULL
Shionogi	NULL
Institute	NULL
for	NULL
Medical	NULL
Science	NULL
,	NULL
Settsu-shi	NULL
,	NULL
Osaka	NULL
566-0022	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Bacteriology	NULL
,	NULL
Kinki	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Osaka-Sayama	NULL
,	NULL
Osaka	NULL
589-8511	NULL
,	NULL
*°	NULL
Japan	NULL
Received	NULL
6	NULL
July	NULL
1998/Returned	NULL
for	NULL
modification	NULL
4	NULL
August	NULL
1998/Accepted	NULL
1	NULL
September	NULL
1998	NULL
Previously	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
TALI	NULL
and	NULL
the	NULL
LIM-only	NULL
protein	NULL
gene	NULL
(	NULL
LMO	NULL
)	NULL
are	NULL
regularly	NULL
coactivated	NULL
in	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
T-ALL	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
is	NULL
likely	NULL
to	NULL
relate	NULL
to	NULL
the	NULL
findings	NULL
that	NULL
TAL1	NULL
and	NULL
LMO	NULL
are	NULL
highly	NULL
synergistic	NULL
in	NULL
T-cell	NULL
tumorigenesis	NULL
in	NULL
double-transgenic	NULL
mice	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
molecular	NULL
mechanisms	NULL
of	NULL
functional	NULL
synergy	NULL
between	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
tumorigenesis	NULL
and	NULL
transcriptional	NULL
regulation	NULL
,	NULL
we	NULL
tried	NULL
to	NULL
identify	NULL
downstream	NULL
target	NULL
genes	NULL
regulated	NULL
by	NULL
TAL	NULL
]	NULL
and	NULL
LMO	NULL
by	NULL
a	NULL
subtractive	NULL
PCR	NULL
method	NULL
.	NULL

One	NULL
of	NULL
the	NULL
isolated	NULL
genes	NULL
,	NULL
that	NULL
for	NULL
retinaldehyde	NULL
dehydrogenase	NULL
2	NULL
(	NULL
RALDH2	NULL
)	NULL
,	NULL
was	NULL
regularly	NULL
expressed	NULL
in	NULL
most	NULL
of	NULL
the	NULL
T-ALL	NULL
cell	NULL
lines	NULL
that	NULL
coexpressed	NULL
TAL	NULL
]	NULL
and	NULL
LMO	NULL
.	NULL

Exogenously	NULL
transfected	NULL
TAL1	NULL
and	NULL
LMO	NULL
,	NULL
but	NULL
not	NULL
either	NULL
alone	NULL
,	NULL
induced	NULL
RA4LDH2	NULL
expression	NULL
in	NULL
a	NULL
T-ALL	NULL
cell	NULL
line	NULL
,	NULL
HPB-ALL	NULL
,	NULL
not	NULL
expressing	NULL
endogeneous	NULL
TAL1	NULL
or	NULL
LMO	NULL
.	NULL

The	NULL
RALDH2	NULL
transcripts	NULL
in	NULL
T-ALL	NULL
were	NULL
,	NULL
however	NULL
,	NULL
mostly	NULL
initiated	NULL
within	NULL
the	NULL
second	NULL
intron	NULL
.	NULL

Promoter	NULL
analysis	NULL
revealed	NULL
that	NULL
a	NULL
GATA	NULL
site	NULL
in	NULL
a	NULL
cryptic	NULL
promoter	NULL
in	NULL
the	NULL
second	NULL
intron	NULL
was	NULL
essential	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
TAL1-and	NULL
LMO-dependent	NULL
transcriptional	NULL
activation	NULL
,	NULL
and	NULL
GATA3	NULL
binds	NULL
to	NULL
this	NULL
site	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
forced	NULL
expression	NULL
of	NULL
GATA3	NULL
potentiated	NULL
the	NULL
induction	NULL
of	NULL
R4LDH2	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
,	NULL
and	NULL
these	NULL
three	NULL
factors	NULL
formed	NULL
a	NULL
complex	NULL
in	NULL
vivo	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
TAL1	NULL
mutant	NULL
not	NULL
binding	NULL
to	NULL
DNA	NULL
also	NULL
activated	NULL
the	NULL
transcription	NULL
of	NULL
RALDH2	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMO	NULL
and	NULL
GATA3	NULL
.	NULL

Collectively	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
the	NULL
RALDH2	NULL
gene	NULL
as	NULL
a	NULL
first	NULL
example	NULL
of	NULL
direct	NULL
transcriptional	NULL
target	NULL
genes	NULL
regulated	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
.	NULL

In	NULL
this	NULL
case	NULL
,	NULL
TAL1	NULL
and	NULL
LMO	NULL
act	NULL
as	NULL
cofactors	NULL
for	NULL
GATA3	NULL
to	NULL
activate	NULL
the	NULL
transcription	NULL
of	NULL
RALDH2	NULL
.	NULL

In	NULL
various	NULL
types	NULL
of	NULL
leukemia	NULL
,	NULL
specific	NULL
recurrent	NULL
chromosomal	NULL
translocations	NULL
are	NULL
frequently	NULL
observed	NULL
and	NULL
potential	NULL
oncogenic	NULL
transcription	NULL
factors	NULL
have	NULL
been	NULL
identified	NULL
from	NULL
the	NULL
chromosomal	NULL
breakpoints	NULL
(	NULL
46	NULL
)	NULL
.	NULL

These	NULL
transcription	NULL
factors	NULL
are	NULL
mostly	NULL
involved	NULL
in	NULL
normal	NULL
hematopoietic	NULL
cell	NULL
differentiation	NULL
and	NULL
growth	NULL
.	NULL

In	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
T-ALL	NULL
)	NULL
,	NULL
frequent	NULL
chromosomal	NULL
abnormalities	NULL
are	NULL
found	NULL
in	NULL
the	NULL
TAL	NULL
]	NULL
(	NULL
also	NULL
called	NULL
SCL	NULL
or	NULL
TCL3	NULL
)	NULL
locus	NULL
(	NULL
5	NULL
,	NULL
9	NULL
,	NULL
10	NULL
,	NULL
14	NULL
)	NULL
.	NULL

Ectopic	NULL
expression	NULL
of	NULL
TAL1	NULL
,	NULL
which	NULL
is	NULL
not	NULL
normally	NULL
expressed	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
44	NULL
,	NULL
57	NULL
)	NULL
,	NULL
is	NULL
observed	NULL
in	NULL
~60	NULL
%	NULL
of	NULL
T-ALL	NULL
patients	NULL
(	NULL
4	NULL
)	NULL
.	NULL

TALI	NULL
encodes	NULL
at	NULL
least	NULL
two	NULL
alternative	NULL
isoforms	NULL
,	NULL
full-length	NULL
TAL1	NULL
«	NULL
and	NULL
N-terminally	NULL
truncated	NULL
TAL1B	NULL
,	NULL
having	NULL
a	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
]	NULL
)	NULL
motif	NULL
found	NULL
in	NULL
a	NULL
number	NULL
of	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
differentiation	NULL
(	NULL
6	NULL
)	NULL
.	NULL

TAL1	NULL
dimer-izes	NULL
with	NULL
ubiquitous	NULL
bHLH	NULL
E-proteins	NULL
(	NULL
E47	NULL
,	NULL
E12	NULL
,	NULL
and	NULL
HEB	NULL
)	NULL
(	NULL
20	NULL
,	NULL
22	NULL
)	NULL
,	NULL
and	NULL
the	NULL
heterodimers	NULL
bind	NULL
to	NULL
the	NULL
E-box	NULL
motif	NULL
(	NULL
CANNTG	NULL
)	NULL
,	NULL
most	NULL
preferably	NULL
to	NULL
AACAGATGGT	NULL
(	NULL
21	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
downstream	NULL
target	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
uncertain	NULL
whether	NULL
TAL1-E-protein	NULL
heterodimers	NULL
regulate	NULL
transcription	NULL
through	NULL
binding	NULL
to	NULL
this	NULL
preferred	NULL
E-box	NULL
.	NULL

LMO1	NULL
(	NULL
RBTN1	NULL
or	NULL
TTG1	NULL
)	NULL
and	NULL
LMO2	NULL
(	NULL
RBTN2	NULL
or	NULL
TTG2	NULL
)	NULL
are	NULL
also	NULL
genes	NULL
originally	NULL
identified	NULL
from	NULL
recurrent	NULL
chromosomal	NULL
breakpoints	NULL
in	NULL
T-ALL	NULL
(	NULL
7	NULL
,	NULL
34	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Their	NULL
expression	NULL
in	NULL
T-ALL	NULL
is	NULL
ectopic	NULL
,	NULL
like	NULL
that	NULL
of	NULL
TAL	NULL
]	NULL
(	NULL
15	NULL
,	NULL
18	NULL
,	NULL
35	NULL
,	NULL
49	NULL
)	NULL
.	NULL

They	NULL
encode	NULL
highly	NULL
related	NULL
LIM-only	NULL
class	NULL
proteins	NULL
(	NULL
LMO	NULL
)	NULL
,	NULL
which	NULL
consist	NULL
of	NULL
only	NULL
two	NULL
tandemly	NULL
repeated	NULL
LIM	NULL
domains	NULL
.	NULL

The	NULL
LIM	NULL
domain	NULL
is	NULL
a	NULL
cysteine-rich	NULL
zinc	NULL
finger-like	NULL
motif	NULL
present	NULL
in	NULL
certain	NULL
homeodomain	NULL
transcription	NULL
factors	NULL
and	NULL
some	NULL
kinases	NULL
and	NULL
cytoskeletal	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Bacteriology	NULL
,	NULL
Kinki	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
377-2	NULL
Ohno-Higashi	NULL
,	NULL
Osaka-Sayama	NULL
,	NULL
Osaka	NULL
589-8511	NULL
,	NULL
Japan	NULL
.	NULL

Phone	NULL
and	NULL
fax	NULL
:	NULL
81-723-67-3606	NULL
.	NULL

E-mail	NULL
:	NULL
o.yoshie	NULL
@	NULL
med.kindai.ac.jp	NULL
.	NULL

6939	NULL
proteins	NULL
,	NULL
and	NULL
it	NULL
appears	NULL
to	NULL
mediate	NULL
protein-protein	NULL
interactions	NULL
(	NULL
45	NULL
,	NULL
51	NULL
)	NULL
.	NULL

LMO	NULL
are	NULL
nuclear	NULL
proteins	NULL
(	NULL
35	NULL
,	NULL
61	NULL
)	NULL
and	NULL
are	NULL
considered	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
transcriptional	NULL
regulation	NULL
,	NULL
even	NULL
though	NULL
they	NULL
do	NULL
not	NULL
have	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

Targeted-disruption	NULL
experiments	NULL
revealed	NULL
that	NULL
both	NULL
TALI	NULL
and	NULL
LMO2	NULL
are	NULL
essential	NULL
for	NULL
embryogenesis	NULL
,	NULL
as	NULL
mutant	NULL
mice	NULL
die	NULL
at	NULL
embryonic	NULL
day	NULL
9.5	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
yolk	NULL
sac	NULL
erythropoiesis	NULL
(	NULL
48	NULL
,	NULL
52	NULL
,	NULL
61	NULL
)	NULL
.	NULL

Since	NULL
TAL1	NULL
and	NULL
LMO2	NULL
physically	NULL
associate	NULL
in	NULL
the	NULL
erythroid	NULL
cell	NULL
lineage	NULL
(	NULL
56	NULL
,	NULL
59	NULL
)	NULL
,	NULL
these	NULL
transcription	NULL
factors	NULL
are	NULL
likely	NULL
to	NULL
regulate	NULL
erythroid	NULL
cell	NULL
differentiation	NULL
and	NULL
growth	NULL
by	NULL
forming	NULL
a	NULL
complex	NULL
.	NULL

Previously	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
TALI	NULL
is	NULL
regularly	NULL
coexpressed	NULL
with	NULL
LMO1	NULL
or	NULL
LMO2	NULL
in	NULL
T-ALL	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
transgenic	NULL
mice	NULL
ectopically	NULL
expressing	NULL
TAL1	NULL
in	NULL
T	NULL
cells	NULL
did	NULL
not	NULL
efficiently	NULL
develop	NULL
tumors	NULL
(	NULL
13	NULL
,	NULL
27	NULL
,	NULL
47	NULL
)	NULL
,	NULL
whereas	NULL
double-transgenic	NULL
mice	NULL
expressing	NULL
TAL1	NULL
and	NULL
LMO	NULL
rapidly	NULL
developed	NULL
leukemia	NULL
(	NULL
2	NULL
,	NULL
30	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
not	NULL
only	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
erythroid	NULL
cell	NULL
differentiation	NULL
but	NULL
also	NULL
in	NULL
the	NULL
development	NULL
of	NULL
T-ALL	NULL
,	NULL
TAL1	NULL
and	NULL
LMO	NULL
act	NULL
synergistically	NULL
,	NULL
most	NULL
probably	NULL
by	NULL
forming	NULL
a	NULL
complex	NULL
(	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
downstream	NULL
target	NULL
genes	NULL
regulated	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
molecular	NULL
mechanism	NULL
by	NULL
which	NULL
these	NULL
factors	NULL
regulate	NULL
transcription	NULL
in	NULL
the	NULL
erythroid	NULL
lineage	NULL
and	NULL
T-ALL	NULL
remains	NULL
mostly	NULL
unknown	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
chromosomal	NULL
abnormalities	NULL
involving	NULL
TALI	NULL
and	NULL
LMO	NULL
are	NULL
highly	NULL
restricted	NULL
to	NULL
T-ALL	NULL
suggests	NULL
that	NULL
some	NULL
other	NULL
T-cell-specific	NULL
cofactor	NULL
(	NULL
s	NULL
)	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
oncogenic	NULL
function	NULL
of	NULL
TAL1	NULL
and	NULL
LMO	NULL
(	NULL
41	NULL
)	NULL
.	NULL

In	NULL
the	NULL
erythroid	NULL
lineage	NULL
,	NULL
LMO2	NULL
physically	NULL
interacts	NULL
with	NULL
GATA1	NULL
as	NULL
well	NULL
as	NULL
TAL1	NULL
and	NULL
bridges	NULL
these	NULL
factors	NULL
to	NULL
form	NULL
a	NULL
larger	NULL
complex	NULL
in	NULL
vivo	NULL
(	NULL
42	NULL
)	NULL
.	NULL

GATA1	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
a	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
conserved	NULL
regulatory	NULL
elements	NULL
among	NULL
many	NULL
erythroid	NULL
cell-specific	NULL
genes	NULL
(	NULL
55	NULL
)	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
GATALI	NULL
blocks	NULL
differentia-	NULL
6940	NULL
ONO	NULL
ET	NULL
AL	NULL
.	NULL

tion	NULL
of	NULL
erythroid	NULL
precursors	NULL
(	NULL
16	NULL
,	NULL
43	NULL
)	NULL
,	NULL
implying	NULL
that	NULL
TAL1	NULL
,	NULL
LMO2	NULL
,	NULL
and	NULL
GATA1	NULL
cooperatively	NULL
regulate	NULL
transcription	NULL
in	NULL
the	NULL
erythroid	NULL
lineage	NULL
.	NULL

Although	NULL
GATA1	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
the	NULL
T-cell	NULL
lineage	NULL
,	NULL
another	NULL
member	NULL
of	NULL
the	NULL
GATA-binding	NULL
protein	NULL
family	NULL
,	NULL
GATA3	NULL
,	NULL
is	NULL
expressed	NULL
(	NULL
19	NULL
,	NULL
28	NULL
,	NULL
33	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
that	NULL
GATA3	NULL
physically	NULL
interacts	NULL
with	NULL
LMO	NULL
in	NULL
vitro	NULL
and	NULL
is	NULL
a	NULL
potent	NULL
cofactor	NULL
for	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
transactivation	NULL
of	NULL
an	NULL
artificial	NULL
reporter	NULL
gene	NULL
in	NULL
a	NULL
T-ALL	NULL
cell	NULL
line	NULL
(	NULL
41	NULL
)	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
mechanism	NULL
of	NULL
T-cell	NULL
tumorigenesis	NULL
and	NULL
transcriptional	NULL
regulation	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
,	NULL
we	NULL
have	NULL
been	NULL
focusing	NULL
on	NULL
downstream	NULL
target	NULL
genes	NULL
of	NULL
these	NULL
factors	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
gene	NULL
for	NULL
a	NULL
T-ALL-specific	NULL
tumor	NULL
marker	NULL
,	NULL
TALLA1	NULL
(	NULL
54	NULL
)	NULL
,	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
one	NULL
such	NULL
gene	NULL
.	NULL

TALLA	NULL
]	NULL
T	NULL
is	NULL
regularly	NULL
coexpressed	NULL
with	NULL
TALI	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
cell	NULL
lines	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Coexpression	NULL
of	NULL
exogeneous	NULL
TAL1	NULL
and	NULL
LMO1	NULL
,	NULL
but	NULL
not	NULL
either	NULL
alone	NULL
,	NULL
strongly	NULL
induced	NULL
TA4LLA	NULL
]	NULL
in	NULL
a	NULL
T-ALL	NULL
cell	NULL
line	NULL
,	NULL
HPB-ALL	NULL
,	NULL
not	NULL
expressing	NULL
endogeneous	NULL
TAL1	NULL
or	NULL
LMO	NULL
(	NULL
41	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
induction	NULL
of	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
remains	NULL
unknown	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
gene	NULL
for	NULL
retinaldehyde	NULL
dehydrogenase	NULL
2	NULL
(	NULL
RALDH2	NULL
)	NULL
(	NULL
63	NULL
)	NULL
is	NULL
also	NULL
induced	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
by	NULL
coexpression	NULL
of	NULL
exogeneous	NULL
TAL1	NULL
and	NULL
LMO	NULL
and	NULL
that	NULL
RA4LDH2	NULL
is	NULL
regularly	NULL
expressed	NULL
in	NULL
most	NULL
T-ALL-derived	NULL
cell	NULL
lines	NULL
ectopically	NULL
coexpressing	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

Promoter	NULL
analysis	NULL
revealed	NULL
that	NULL
a	NULL
transcriptional	NULL
complex	NULL
containing	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
binds	NULL
to	NULL
a	NULL
GATA	NULL
site	NULL
in	NULL
a	NULL
cryptic	NULL
promoter	NULL
in	NULL
the	NULL
second	NULL
intron	NULL
of	NULL
the	NULL
RALDH2	NULL
gene	NULL
and	NULL
regulates	NULL
transcription	NULL
through	NULL
this	NULL
site	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
RALDH2	NULL
gene	NULL
is	NULL
a	NULL
direct	NULL
target	NULL
gene	NULL
regulated	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
,	NULL
and	NULL
in	NULL
this	NULL
case	NULL
TAL1	NULL
and	NULL
LMO	NULL
act	NULL
as	NULL
cofactors	NULL
for	NULL
GATA3	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
.	NULL

Hematopoietic	NULL
cell	NULL
lines	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

For	NULL
details	NULL
of	NULL
each	NULL
T-ALL	NULL
cell	NULL
line	NULL
,	NULL
see	NULL
reference	NULL
54	NULL
.	NULL

HPB-ALL	NULL
clones	NULL
stably	NULL
expressing	NULL
TAL1a	NULL
«	NULL
and/or	NULL
LMO1	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

293E	NULL
and	NULL
COS	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

PCR-based	NULL
subtraction	NULL
.	NULL

Suppression-subtractive	NULL
hybridization	NULL
between	NULL
parental	NULL
HPB-ALL	NULL
cells	NULL
and	NULL
HPB-ALL	NULL
cells	NULL
stably	NULL
expressing	NULL
TAL1	NULL
«	NULL
and	NULL
LMO1	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
a	NULL
PCR-Select	NULL
cDNA	NULL
subtraction	NULL
kit	NULL
(	NULL
Clontech	NULL
)	NULL
according	NULL
to	NULL
the	NULL
protocol	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Obtained	NULL
PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
Rsel	NULL
and	NULL
ligated	NULL
with	NULL
AD1	NULL
adapter	NULL
.	NULL

AD1-ligated	NULL
tester	NULL
cDNA	NULL
(	NULL
300	NULL
pg	NULL
)	NULL
and	NULL
driver	NULL
cDNA	NULL
(	NULL
300	NULL
ng	NULL
)	NULL
were	NULL
hybridized	NULL
and	NULL
amplified	NULL
by	NULL
using	NULL
ADIS	NULL
primer	NULL
.	NULL

PCR	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
Rsal	NULL
and	NULL
ligated	NULL
with	NULL
AD2	NULL
adapter	NULL
.	NULL

AD2-ligated	NULL
tester	NULL
cDNA	NULL
(	NULL
10	NULL
pg	NULL
)	NULL
and	NULL
driver	NULL
cDNA	NULL
(	NULL
300	NULL
ng	NULL
)	NULL
were	NULL
hybridized	NULL
and	NULL
amplified	NULL
by	NULL
using	NULL
AD2S	NULL
primer	NULL
.	NULL

Amplified	NULL
fragments	NULL
were	NULL
cloned	NULL
into	NULL
pCRII	NULL
(	NULL
Invitrogen	NULL
)	NULL
.	NULL

All	NULL
PCRs	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
Pfz	NULL
DNA	NULL
polymerase	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

Adapter	NULL
sequences	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
AD1S	NULL
,	NULL
5-CAGCTCCACAACCTACATCA	NULL
TTCCGT-3	NULL
'	NULL
;	NULL
ADIA	NULL
,	NULL
5'-ACGGAATGATGT-3	NULL
'	NULL
;	NULL
AD2S	NULL
,	NULL
5-GTCCATCTTCTC	NULL
TCTGAGACTCTGGT-3	NULL
'	NULL
;	NULL
and	NULL
AD2A	NULL
,	NULL
5-ACCAGAGTCTCA-3	NULL
'	NULL
.	NULL

AD1IS-AD1IA	NULL
and	NULL
AD2S-AD2A	NULL
were	NULL
annealed	NULL
,	NULL
yielding	NULL
AD1	NULL
and	NULL
AD2	NULL
,	NULL
respectively	NULL
.	NULL

Isolation	NULL
of	NULL
RALDH2Z	NULL
cDNA	NULL
and	NULL
genomic	NULL
clones	NULL
.	NULL

A	NULL
Jurkat	NULL
cDNA	NULL
library	NULL
(	NULL
Clontech	NULL
)	NULL
was	NULL
screened	NULL
by	NULL
colony	NULL
hybridization	NULL
,	NULL
using	NULL
as	NULL
a	NULL
probe	NULL
*°P-radiola-beled	NULL
cDNA	NULL
fragments	NULL
obtained	NULL
by	NULL
subtractive	NULL
PCR	NULL
.	NULL

Four	NULL
clones	NULL
were	NULL
analyzed	NULL
by	NULL
DNA	NULL
sequencing	NULL
,	NULL
and	NULL
then	NULL
5	NULL
'	NULL
rapid	NULL
amplification	NULL
of	NULL
cDNA	NULL
ends	NULL
(	NULL
RACE	NULL
)	NULL
was	NULL
performed	NULL
with	NULL
Molt4	NULL
and	NULL
K562	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
RNAs	NULL
.	NULL

Amplified	NULL
products	NULL
were	NULL
cloned	NULL
into	NULL
pCRII	NULL
(	NULL
Invitrogen	NULL
)	NULL
,	NULL
and	NULL
several	NULL
clones	NULL
were	NULL
sequenced	NULL
.	NULL

Full-length	NULL
cDNAs	NULL
were	NULL
amplified	NULL
from	NULL
Molt4	NULL
and	NULL
K562	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNAs	NULL
by	NULL
reverse	NULL
tran-scription-PCR	NULL
(	NULL
RT-PCR	NULL
)	NULL
with	NULL
primers	NULL
designed	NULL
from	NULL
the	NULL
sequence	NULL
of	NULL
5'RACE	NULL
products	NULL
and	NULL
the	NULL
Jurkat	NULL
cDNA	NULL
,	NULL
and	NULL
several	NULL
clones	NULL
were	NULL
sequenced	NULL
.	NULL

Genomic	NULL
clones	NULL
were	NULL
obtained	NULL
by	NULL
screening	NULL
a	NULL
human	NULL
genomic	NULL
library	NULL
by	NULL
using	NULL
the	NULL
P-labeled	NULL
5	NULL
'	NULL
portion	NULL
of	NULL
the	NULL
Molt4	NULL
RALDH2	NULL
cDNA	NULL
fragment	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

The	NULL
inserts	NULL
of	NULL
positive	NULL
clones	NULL
were	NULL
subcloned	NULL
into	NULL
pBluescriptII	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
sequenced	NULL
from	NULL
both	NULL
directions	NULL
.	NULL

Northern	NULL
blotting	NULL
and	NULL
RT-PCR	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
from	NULL
various	NULL
cell	NULL
lines	NULL
by	NULL
using	NULL
Trizol	NULL
reagent	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
purified	NULL
with	NULL
an	NULL
mRNA	NULL
purification	NULL
kit	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Two	NULL
micrograms	NULL
of	NULL
each	NULL
poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
was	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
containing	NULL
formaldehyde	NULL
and	NULL
blotted	NULL
onto	NULL
a	NULL
nylon	NULL
membrane	NULL
.	NULL

Filters	NULL
were	NULL
hybridized	NULL
with	NULL
``	NULL
P-labeled	NULL
probes	NULL
by	NULL
using	NULL
QuikHyb	NULL
hybridization	NULL
solution	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
washed	NULL
at	NULL
60°C	NULL
in	NULL
0.1	NULL
%	NULL
SSC	NULL
(	NULL
1	NULL
%	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
-0.1	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
.	NULL

RT-PCR	NULL
was	NULL
performed	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Amplification	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
denaturation	NULL
at	NULL
94°C	NULL
for	NULL
1	NULL
min	NULL
(	NULL
3	NULL
min	NULL
in	NULL
the	NULL
first	NULL
cycle	NULL
)	NULL
,	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

annealing	NULL
at	NULL
65°C	NULL
for	NULL
1	NULL
min	NULL
,	NULL
and	NULL
extension	NULL
at	NULL
72°C	NULL
for	NULL
1	NULL
min	NULL
(	NULL
3	NULL
min	NULL
in	NULL
the	NULL
last	NULL
cycle	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
cycles	NULL
was	NULL
28	NULL
for	NULL
F1-R1	NULL
,	NULL
37	NULL
for	NULL
F2-R1	NULL
,	NULL
30	NULL
for	NULL
F3-R1	NULL
,	NULL
and	NULL
35	NULL
for	NULL
detection	NULL
of	NULL
E2A	NULL
and	NULL
RALDH2	NULL
in	NULL
transiently	NULL
transfected	NULL
HPB-ALL	NULL
cells	NULL
.	NULL

Primer	NULL
sequences	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
F1	NULL
,	NULL
5'-AACAACGAGTGGCAGAACTCAG	NULL
AGAG-3	NULL
'	NULL
;	NULL
F2	NULL
,	NULL
F3	NULL
,	NULL
ACAAAG	NULL
CAGTGCAGGCAGCC-3	NULL
'	NULL
;	NULL
R1	NULL
,	NULL
ATCGAAAGGTTITGATGACGCCCTGC-3	NULL
'	NULL
;	NULL
RALDH2	NULL
in	NULL
transiently	NULL
transfected	NULL
HPB-ALL	NULL
cells	NULL
,	NULL
5-AGGAGATACTG	NULL
GATGTGTCTGCTAGC-3	NULL
'	NULL
and	NULL
5-CTCACAGTGTCITCTGCAATGCAAG	NULL
C-3	NULL
'	NULL
;	NULL
and	NULL
E24	NULL
,	NULL
5-CAGCAGGGTTTCCAGGCCTGAGGTGC-3	NULL
'	NULL
and	NULL
5-GCT	NULL
GCTGTGCGACTCAGTGAAGTGGG-3	NULL
'	NULL
.	NULL

Transfection	NULL
and	NULL
luciferase	NULL
assay	NULL
.	NULL

Expression	NULL
vectors	NULL
for	NULL
TAL1	NULL
,	NULL
LMO1	NULL
,	NULL
LMO2	NULL
,	NULL
and	NULL
GATA3	NULL
were	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
41	NULL
)	NULL
.	NULL

The	NULL
GATA3	NULL
KRR	NULL
mutant	NULL
(	NULL
pc-KRR	NULL
)	NULL
was	NULL
kindly	NULL
provided	NULL
by	NULL
Astar	NULL
Winoto	NULL
(	NULL
53	NULL
)	NULL
.	NULL

The	NULL
EcoRI	NULL
fragment	NULL
of	NULL
pc-KRR	NULL
was	NULL
inserted	NULL
into	NULL
pMIKneo	NULL
,	NULL
yielding	NULL
pMIKneoGATA3KRR	NULL
.	NULL

The	NULL
GATA3CFM	NULL
mutant	NULL
was	NULL
constructed	NULL
by	NULL
PCR	NULL
with	NULL
mutant	NULL
primers	NULL
changing	NULL
Cys	NULL
(	NULL
317	NULL
)	NULL
and	NULL
Cys	NULL
(	NULL
320	NULL
)	NULL
to	NULL
Gly	NULL
.	NULL

The	NULL
TAL1BBM	NULL
mutant	NULL
was	NULL
also	NULL
constructed	NULL
by	NULL
PCR	NULL
changing	NULL
Arg-Glu-Arg	NULL
(	NULL
20-22	NULL
)	NULL
to	NULL
Ala-Ala-Ala.	NULL
To	NULL
make	NULL
a	NULL
series	NULL
of	NULL
RALDH2-T	NULL
reporter	NULL
plasmids	NULL
,	NULL
cach	NULL
genomic	NULL
fragment	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
5-GAGGAGCTCCCTTCTCCACACTGAACCAAGAGAG-3	NULL
'	NULL
and	NULL
the	NULL
following	NULL
primers	NULL
:	NULL
-1.7-luc	NULL
,	NULL
5-GAGGGTACCGAGTGTAGGTITGGAGTG	NULL
ATGTAGG-3	NULL
'	NULL
;	NULL
-308-lue	NULL
,	NULL
5'-GAGGGTACCGAGTGTTCCCTGTCTATAAT	NULL
CCAGCC-3	NULL
'	NULL
;	NULL
-267-lue	NULL
,	NULL
5-GAGGGTACCTGTGAAGTTCAAGAAGCAGAC	NULL
AAGG-3	NULL
'	NULL
;	NULL
-231-lue	NULL
,	NULL
TAA-3	NULL
'	NULL
;	NULL
-228-lue	NULL
,	NULL
5-GAGGGTACCATAAAAGATTTCCTATGAAATAAC	NULL
TG-3	NULL
'	NULL
;	NULL
-207-lue	NULL
,	NULL
5-GAGGGTACCAACTGCCTTCAAACAGCAGAGCAGC	NULL
A-3	NULL
'	NULL
;	NULL
-181-lue	NULL
,	NULL
5-GAGGGTACCAACATATGCTCTCAGTACACCACTAC-3	NULL
'	NULL
;	NULL
and	NULL
-142-lue	NULL
,	NULL
5-GAGGGTACCACTTITITCATGACAGTGGATGGTT	NULL
C-3	NULL
'	NULL
.	NULL

Amplified	NULL
fragments	NULL
were	NULL
inserted	NULL
into	NULL
the	NULL
KprI-SecI	NULL
site	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
pGV-B	NULL
(	NULL
TOYO	NULL
Ink	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

To	NULL
make	NULL
tk-luc	NULL
,	NULL
the	NULL
herpes	NULL
simplex	NULL
virus	NULL
(	NULL
HSV	NULL
)	NULL
thymidine	NULL
kinase	NULL
(	NULL
#	NULL
)	NULL
minimal	NULL
promoter	NULL
(	NULL
36	NULL
)	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
5-GAGAGATCTCAGTCGGGGCGGCGCGGTCC-3	NULL
'	NULL
and	NULL
5'-GAGAAGCTTCGGTCGCTCGGTGTTCGAGG-3	NULL
'	NULL
,	NULL
digested	NULL
with	NULL
Bg/II	NULL
and	NULL
HindIII	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
same	NULL
site	NULL
of	NULL
pGV-B	NULL
.	NULL

To	NULL
make	NULL
GATAX3-tk-luc	NULL
,	NULL
two	NULL
synthetic	NULL
oligonucleotides	NULL
,	NULL
5	NULL
``	NULL
-CGTAGATAAAAGTAGATAAAAGTAGATA	NULL
AAAGAGCT-3	NULL
'	NULL
and	NULL
5-CTTTTATCTACTTTTATCTACTTTTATCTACGGT	NULL
AC-3	NULL
'	NULL
,	NULL
were	NULL
annealed	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
KprI-Sacl	NULL
site	NULL
of	NULL
tk-luc	NULL
.	NULL

Recipient	NULL
cells	NULL
(	NULL
10	NULL
``	NULL
)	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
with	NULL
various	NULL
combinations	NULL
of	NULL
plasmids	NULL
together	NULL
with	NULL
0.1	NULL
ug	NULL
of	NULL
pRL-CMV	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
by	NULL
using	NULL
the	NULL
Dual-luciferase	NULL
reporter	NULL
assay	NULL
system	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
normalized	NULL
with	NULL
Renilla	NULL
luciferase	NULL
activity	NULL
.	NULL

Immunoprecipitation	NULL
.	NULL

Two	NULL
synthetic	NULL
oligonucleotides	NULL
,	NULL
5	NULL
-AATTGCCACCAT	NULL
GGACTACAAGGACGACGACGACAAGGAATTCCCGGGTCGACA-3	NULL
'	NULL
and	NULL
5-CTAGTGTCGACCCGGGAATTCCTTGTCGTCGTCGTCCITGTAG	NULL
TCCATGGTGGC-3	NULL
'	NULL
,	NULL
were	NULL
annealed	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI-Spel	NULL
site	NULL
of	NULL
pMIKneo	NULL
,	NULL
yielding	NULL
pMIKneoFLAG	NULL
.	NULL

Two	NULL
synthetic	NULL
oligonucleotides	NULL
,	NULL
5'-AATT	NULL
GCCACCATGGACTACCCATACGACGTCCCAGACTACGCTGAATTCC	NULL
CGGGTCGACA-3	NULL
'	NULL
and	NULL
5-CTAGTGTCGACCCGGGAATTCAGCGTAG	NULL
TCTGGGACGTCGTATGGGTAGTCCATGGTGGC-3	NULL
'	NULL
,	NULL
were	NULL
annealed	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
EcoRI-Spel	NULL
site	NULL
of	NULL
pMIKneo	NULL
,	NULL
yielding	NULL
pMIKneoHA	NULL
.	NULL

cDNAs	NULL
of	NULL
TALIB	NULL
,	NULL
TAL1BBM	NULL
,	NULL
LMO1	NULL
,	NULL
LMO2	NULL
,	NULL
GATA3	NULL
,	NULL
GATA3CFM	NULL
,	NULL
and	NULL
E47S	NULL
were	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
the	NULL
following	NULL
primer	NULL
sets	NULL
:	NULL
TAL1B	NULL
,	NULL
5-GAGGAATTCA	NULL
TGGAGATTACTGATGGTCC-3	NULL
'	NULL
and	NULL
5-GAGGTCGACGGATCCTCACCG	NULL
AGGGCCGGCTCCATC-3	NULL
'	NULL
;	NULL
TAL1BBM	NULL
,	NULL
5-GAGGAATTCATGGAGATTAC	NULL
TGATGGTCC-3	NULL
'	NULL
and	NULL
5-GAGGAATTCTGATCCTGGTGGCCCAGACCCA	NULL
TCAC.-3	NULL
'	NULL
;	NULL
LMO1	NULL
,	NULL
and	NULL
5'-GAGGTCGACGGATCCCGTTACTGAACTTGGGATTC-3	NULL
'	NULL
;	NULL
LMO2	NULL
,	NULL
5'-G	NULL
AGGAATTCATGTCCTCGGCCATCGAAAG-3	NULL
'	NULL
and	NULL
5-GAGGTCGACGG	NULL
ATCCCCTATATCATCCCATTGATC-3	NULL
'	NULL
;	NULL
GATA3	NULL
and	NULL
GATA3CFM	NULL
,	NULL
5-GAG	NULL
GAATTCATGGAGGTGACGGCGGACCAGCCGCG-3	NULL
'	NULL
and	NULL
5'-GAGGAAT	NULL
TCGTGAGCATCGAGCAGGGCTCTAACCC-3	NULL
'	NULL
,	NULL
and	NULL
B47S	NULL
,	NULL
5-GAGGAATT	NULL
CAGTACGGACGAGGTGCTGTC-3	NULL
'	NULL
and	NULL
5-GAGGAATTCCTCGTCCCAC	NULL
GGAGGCATAC-3	NULL
'	NULL
.	NULL

TAL1B	NULL
,	NULL
LMO1	NULL
,	NULL
and	NULL
LMO2	NULL
fragments	NULL
were	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
Seil	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
same	NULL
site	NULL
of	NULL
pMIKneoFLAG	NULL
and	NULL
pMIKneoHA	NULL
.	NULL

TAL1BBM	NULL
,	NULL
GATA3	NULL
,	NULL
GATA3CFM	NULL
,	NULL
and	NULL
E47S	NULL
fragments	NULL
were	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
same	NULL
site	NULL
of	NULL
pMIKneoFLAG	NULL
and	NULL
pMIKneoHA	NULL
.	NULL

293E	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
various	NULL
combinations	NULL
of	NULL
5	NULL
pg	NULL
of	NULL
each	NULL
plasmid	NULL
by	NULL
using	NULL
Lipofectamine	NULL
Plus	NULL
reagent	NULL
(	NULL
GIBCO	NULL
BRL	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
600	NULL
pl	NULL
of	NULL
low-stringency	NULL
Nonidet	NULL
P40	NULL
(	NULL
NP-40	NULL
)	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.6	NULL
]	NULL
,	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
%	NULL
NP-40	NULL
)	NULL
(	NULL
56	NULL
)	NULL
and	NULL
immunoprecipitated	NULL
with	NULL
anti-FLAG	NULL
antibody	NULL
(	NULL
Kodak	NULL
)	NULL
.	NULL

After	NULL
washing	NULL
five	NULL
times	NULL
with	NULL
cold	NULL
low-stringency	NULL
NP-40	NULL
buffer	NULL
,	NULL
immunoprecipitates	NULL
were	NULL
analyzed	NULL
by	NULL
immu-noblotting	NULL
with	NULL
anti-FLAG	NULL
or	NULL
antihemagglutinin	NULL
(	NULL
anti-HA	NULL
)	NULL
(	NULL
Boehringer	NULL
Mann-heim	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
of	NULL
transfected	NULL
293E	NULL
or	NULL
COS	NULL
cells	NULL
were	NULL
prepared	NULL
by	NULL
using	NULL
low-stringency	NULL
NP-40	NULL
buffer	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
HPB-ALL	NULL
cells	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Double-stranded	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
end	NULL
labeled	NULL
by	NULL
using	NULL
[	NULL
y-*°P	NULL
]	NULL
ATP	NULL
and	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

One	NULL
microliter	NULL
of	NULL
cell	NULL
lysates	NULL
or	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
was	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
competitors	NULL
(	NULL
100	NULL
ng	NULL
)	NULL
,	NULL
anti-FLAG	NULL
monoclonal	NULL
antibody	NULL
(	NULL
MAb	NULL
)	NULL
(	NULL
2.8	NULL
pg	NULL
)	NULL
,	NULL
or	NULL
anti-GATA3	NULL
MAb	NULL
(	NULL
0.2	NULL
ug	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
for	NULL
5	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
and	NULL
then	NULL
with	NULL
radiolabeled	NULL
probes	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cpm/ng	NULL
;	NULL
0.5	NULL
ng/reaction	NULL
mixture	NULL
)	NULL
for	NULL
another	NULL
20	NULL
min	NULL
at	NULL
room	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
temperature	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
a	NULL
solution	NULL
consisting	NULL
of	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
and	NULL
0.5	NULL
ug	NULL
(	NULL
293E	NULL
and	NULL
COS	NULL
cell	NULL
lysates	NULL
)	NULL
or	NULL
2	NULL
mg	NULL
(	NULL
HPB-ALL	NULL
nuclear	NULL
extract	NULL
)	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
with	NULL
TAE	NULL
buffer	NULL
(	NULL
7	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
3	NULL
mM	NULL
sodium	NULL
acetate	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
at	NULL
120	NULL
V	NULL
for	NULL
1.5	NULL
h.	NULL
Gels	NULL
were	NULL
dried	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

Oligonucleotide	NULL
probes	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
TAL1CS	NULL
,	NULL
5-ACCTGAACAGATGGTCGGCT-3	NULL
'	NULL
and	NULL
5'-AGCCGA	NULL
CCATCTGTTCAGGT-3	NULL
'	NULL
;	NULL
TCR-GATA	NULL
,	NULL
5	NULL
``	NULL
-GTTAGAGATAGCATCGCCCC-3	NULL
'	NULL
and	NULL
5	NULL
%	NULL
-GGGGCGATGCTATCTCTAAC-3	NULL
'	NULL
;	NULL
RALDH2-GATA	NULL
,	NULL
5'-GGCCCC	NULL
TTTTGTAGATAAAAGATTTCCGGG-3	NULL
'	NULL
and	NULL
5-CCCGGAAATCTTTTATC	NULL
TACAAAAGGGGGCC-3	NULL
'	NULL
;	NULL
and	NULL
RALDH2-GATAM	NULL
,	NULL
5-GGCCCCTTTTGTTC	NULL
TAGAAAGATTTCCGGG-3	NULL
'	NULL
and	NULL
5'-CCCGGAAATCTTTCTAGAACAAAA	NULL
GGGaCC-3	NULL
'	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
accession	NULL
numbers	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
of	NULL
human	NULL
RALDH2	NULL
cDNA	NULL
are	NULL
listed	NULL
in	NULL
the	NULL
DDBJ/EMBL/GenBank	NULL
database	NULL
under	NULL
accession	NULL
no	NULL
.	NULL

ABO15226	NULL
,	NULL
ABO15227	NULL
,	NULL
and	NULL
ABO15228	NULL
.	NULL

The	NULL
sequence	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
is	NULL
listed	NULL
in	NULL
the	NULL
DDBJ/EMBL/GenBank	NULL
database	NULL
under	NULL
accession	NULL
no	NULL
.	NULL

ABO15229	NULL
.	NULL

RESULTS	NULL
RALDH	NULL
]	NULL
2	NULL
is	NULL
induced	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
.	NULL

To	NULL
identify	NULL
target	NULL
genes	NULL
regulated	NULL
by	NULL
ectopically	NULL
coexpressed	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
,	NULL
we	NULL
used	NULL
a	NULL
T-ALL-derived	NULL
cell	NULL
line	NULL
,	NULL
HPB-ALL	NULL
,	NULL
not	NULL
expressing	NULL
TAL1	NULL
or	NULL
LMO	NULL
and	NULL
its	NULL
subline	NULL
stably	NULL
expressing	NULL
transfected	NULL
TAL1a	NULL
«	NULL
and	NULL
LMO1	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Using	NULL
suppression-subtractive	NULL
hybridization	NULL
followed	NULL
by	NULL
two	NULL
cycles	NULL
of	NULL
subtractive	NULL
PCR	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
we	NULL
obtained	NULL
several	NULL
fragments	NULL
of	NULL
genes	NULL
whose	NULL
expression	NULL
was	NULL
strongly	NULL
up-regulated	NULL
in	NULL
the	NULL
subline	NULL
coexpressing	NULL
TAL1	NULL
«	NULL
and	NULL
LMO1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Four	NULL
of	NULL
these	NULL
fragments	NULL
were	NULL
derived	NULL
from	NULL
the	NULL
same	NULL
gene	NULL
.	NULL

Since	NULL
the	NULL
encoded	NULL
amino	NULL
acid	NULL
sequence	NULL
is	NULL
98	NULL
%	NULL
identical	NULL
to	NULL
mouse	NULL
RALDH2	NULL
(	NULL
63	NULL
)	NULL
,	NULL
this	NULL
gene	NULL
is	NULL
the	NULL
human	NULL
counterpart	NULL
of	NULL
the	NULL
RALDH2	NULL
gene	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
roles	NULL
of	NULL
TAL1	NULL
«	NULL
and	NULL
LMO1	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
RALDH2	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
RALDH2	NULL
in	NULL
a	NULL
panel	NULL
of	NULL
HPB-ALL	NULL
clones	NULL
stably	NULL
expressing	NULL
transfected	NULL
TAL1a	NULL
«	NULL
or	NULL
LMO1	NULL
or	NULL
both	NULL
(	NULL
41	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
the	NULL
vector	NULL
control	NULL
clones	NULL
and	NULL
those	NULL
expressing	NULL
either	NULL
TAL1a	NULL
or	NULL
LMO1	NULL
alone	NULL
did	NULL
not	NULL
express	NULL
RALDH2	NULL
at	NULL
all	NULL
,	NULL
whereas	NULL
those	NULL
coexpressing	NULL
both	NULL
TAL1a	NULL
«	NULL
and	NULL
LMO1	NULL
strongly	NULL
expressed	NULL
it	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
possible	NULL
clonal	NULL
variations	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
HPB-ALL	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
TAL1	NULL
and	NULL
LMO	NULL
expression	NULL
vectors	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
results	NULL
obtained	NULL
with	NULL
stable	NULL
clones	NULL
,	NULL
only	NULL
HPB-ALL	NULL
cells	NULL
cotransfected	NULL
with	NULL
TALla	NULL
«	NULL
and	NULL
LMO1	NULL
expressed	NULL
RALDH2	NULL
.	NULL

Furthermore	NULL
,	NULL
even	NULL
the	NULL
N-terminally	NULL
truncated	NULL
isoform	NULL
TAL1B	NULL
induced	NULL
RALDH2	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMO1	NULL
or	NULL
LMO2	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
RALDH2	NULL
is	NULL
a	NULL
transcriptional	NULL
downstream	NULL
target	NULL
gene	NULL
of	NULL
TAL1	NULL
and	NULL
LMO	NULL
and	NULL
that	NULL
both	NULL
TAL1	NULL
and	NULL
LMO	NULL
are	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
RALDH2	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
expression	NULL
of	NULL
RALDH2	NULL
is	NULL
regularly	NULL
associated	NULL
with	NULL
ectopic	NULL
expression	NULL
of	NULL
TALI	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
,	NULL
we	NULL
performed	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
13	NULL
T-ALL	NULL
cell	NULL
lines	NULL
(	NULL
54	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
HPB-ALL	NULL
,	NULL
DND4.1	NULL
,	NULL
and	NULL
TALL-1	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
neither	NULL
TAL	NULL
]	NULL
nor	NULL
LMO	NULL
(	NULL
41	NULL
)	NULL
,	NULL
did	NULL
not	NULL
express	NULL
RALDH2	NULL
either	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
except	NULL
for	NULL
Molt15	NULL
and	NULL
Molt17	NULL
,	NULL
all	NULL
of	NULL
the	NULL
T-ALL	NULL
cell	NULL
lines	NULL
that	NULL
co-express	NULL
TALI	NULL
and	NULL
either	NULL
LMO1	NULL
or	NULL
LMO2	NULL
(	NULL
41	NULL
)	NULL
also	NULL
expressed	NULL
RALDH2	NULL
.	NULL

Although	NULL
Molt15	NULL
and	NULL
Molt17	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
the	NULL
only	NULL
T-ALL	NULL
cell	NULL
lines	NULL
with	NULL
the	NULL
CD4~_	NULL
CD8~	NULL
double-negative	NULL
phenotype	NULL
(	NULL
54	NULL
)	NULL
,	NULL
did	NULL
not	NULL
express	NULL
RALDH2	NULL
despite	NULL
coexpression	NULL
of	NULL
TAL	NULL
]	NULL
and	NULL
LMO2	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
RALDH2	NULL
is	NULL
indeed	NULL
induced	NULL
by	NULL
coactivation	NULL
of	NULL
TALI	NULL
and	NULL
LMO	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
T-ALL	NULL
.	NULL

Among	NULL
other	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
tested	NULL
,	NULL
K562	NULL
,	NULL
which	NULL
is	NULL
an	NULL
erythroleukemia-derived	NULL
cell	NULL
line	NULL
endogenously	NULL
expressing	NULL
TALI	NULL
and	NULL
LMO2	NULL
,	NULL
also	NULL
expressed	NULL
RALDH2	NULL
(	NULL
Fig	NULL
.	NULL

1D	NULL
)	NULL
.	NULL

Transcription	NULL
of	NULL
RALDH2	NULL
in	NULL
T-ALL	NULL
starts	NULL
from	NULL
a	NULL
T-ALL-specific	NULL
promoter	NULL
.	NULL

Full-length	NULL
cDNA	NULL
clones	NULL
of	NULL
RALDH2	NULL
were	NULL
INDUCTION	NULL
OF	NULL
RALDH2	NULL
BY	NULL
TALl	NULL
AND	NULL
LMO	NULL
IN	NULL
T-ALL	NULL
_	NULL
6941	NULL
A	NULL
TAI	NULL
;	NULL
1a	NULL
--	NULL
TAL1ia	NULL
@	NULL
LMO1	NULL
LMO1	NULL
W	NULL
@	NULL
I|	NULL
B	NULL
TALia	NULL
+	NULL
--	NULL
LMO1	NULL
LMO2	NULL
TAL1i	NULL
@	NULL
LMO1	NULL
m__	NULL
m__	NULL
m__	NULL
mm	NULL
rm	NULL
RALDH2	NULL
E2A	NULL
TALic	NULL
TAL1B	NULL
TAL1B	NULL
+	NULL
+	NULL
+	NULL
LMO2	NULL
TAL1B	NULL
LMO1	NULL
-	NULL
LMO2	NULL
mm	NULL
mm	NULL
mms	NULL
Crm	NULL
RALDH2	NULL
E2A	NULL
e	NULL
]	NULL
PZ	NULL
]	NULL
«	NULL
l	NULL
&	NULL
-	NULL
r-sa	NULL
<	NULL
4	NULL
W	NULL
©	NULL
ots	NULL
eq	NULL
tow	NULL
¥	NULL
§	NULL
s	NULL
a	NULL
a	NULL
2	NULL
%	NULL
5	NULL
Eo	NULL
z	NULL
_	NULL
1	NULL
0	NULL
@	NULL
5	NULL
5	NULL
&	NULL
8	NULL
$	NULL
$	NULL
f	NULL
$	NULL
g	NULL
5	NULL
c	NULL
§	NULL
$	NULL
[	NULL
60	NULL
w	NULL
»	NULL
“	NULL
g.	NULL
“	NULL
TAU	NULL
see	NULL
-	NULL
Oe	NULL
Q.	NULL
RALDH2	NULL
I	NULL
G3PDH	NULL
BALL-1	NULL
Raji	NULL
HL6O	NULL
u937	NULL
M	NULL
|xse2	NULL
RALDH2	NULL
G3PDH	NULL
|	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Induction	NULL
of	NULL
RALDH2	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
for	NULL
RALDFT2	NULL
in	NULL
HPB-ALL	NULL
clones	NULL
.	NULL

HPB-ALL	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
indicated	NULL
combinations	NULL
of	NULL
expression	NULL
vectors	NULL
,	NULL
and	NULL
stable	NULL
transformants	NULL
were	NULL
isolated	NULL
.	NULL

Two	NULL
clones	NULL
were	NULL
analyzed	NULL
for	NULL
each	NULL
combination	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
2	NULL
ug	NULL
each	NULL
)	NULL
was	NULL
electrophoresed	NULL
,	NULL
blotted	NULL
onto	NULL
a	NULL
filter	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
the	NULL
*°P-labeled	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
RALDHZ	NULL
cDNA	NULL
obtained	NULL
by	NULL
subtractive	NULL
PCR	NULL
.	NULL

The	NULL
same	NULL
filter	NULL
was	NULL
reprobed	NULL
for	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
G3PDH	NULL
)	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
RT-PCR	NULL
analysis	NULL
for	NULL
RALDH2	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
transiently	NULL
expressing	NULL
the	NULL
indicated	NULL
combinations	NULL
of	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

HPB-ALL	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
15	NULL
pg	NULL
each	NULL
of	NULL
the	NULL
indicated	NULL
expression	NULL
vectors	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
pRC/CMV-luc	NULL
by	NULL
electroporation	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
analysis	NULL
for	NULL
RALDH2	NULL
and	NULL
E24	NULL
(	NULL
control	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
total	NULL
RNA	NULL
used	NULL
were	NULL
10	NULL
,	NULL
2	NULL
,	NULL
and	NULL
0.4	NULL
ng	NULL
from	NULL
left	NULL
to	NULL
right	NULL
.	NULL

Amplification	NULL
products	NULL
were	NULL
electrophoresed	NULL
on	NULL
2	NULL
%	NULL
agarose	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
tested	NULL
by	NULL
luciferase	NULL
assay	NULL
and	NULL
varied	NULL
within	NULL
threefold	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Northern	NULL
blot	NULL
analysis	NULL
for	NULL
RALDFH2	NULL
in	NULL
T-ALL-derived	NULL
cell	NULL
lines	NULL
(	NULL
C	NULL
)	NULL
and	NULL
other	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Poly	NULL
(	NULL
A	NULL
)	NULL
*	NULL
RNA	NULL
(	NULL
2	NULL
mg	NULL
each	NULL
)	NULL
was	NULL
examined	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
A.	NULL
BALL-1	NULL
and	NULL
Raji	NULL
,	NULL
B-cell	NULL
lines	NULL
,	NULL
HL60	NULL
,	NULL
promyelocytic	NULL
cell	NULL
line	NULL
;	NULL
U937	NULL
,	NULL
mono-cytoid	NULL
cell	NULL
line	NULL
;	NULL
K562	NULL
,	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
.	NULL

6942	NULL
ONO	NULL
ET	NULL
AL	NULL
.	NULL

obtained	NULL
from	NULL
Molt4	NULL
and	NULL
K562	NULL
cells	NULL
.	NULL

The	NULL
coding	NULL
sequence	NULL
of	NULL
cDNA	NULL
obtained	NULL
from	NULL
K562	NULL
cells	NULL
showed	NULL
a	NULL
striking	NULL
homology	NULL
to	NULL
the	NULL
mouse	NULL
RALDH2	NULL
gene	NULL
,	NULL
and	NULL
the	NULL
deduced	NULL
amino	NULL
acid	NULL
sequence	NULL
was	NULL
98	NULL
%	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
mouse	NULL
RALDH2	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
5	NULL
portion	NULL
of	NULL
cDNA	NULL
obtained	NULL
from	NULL
Molt4	NULL
cells	NULL
was	NULL
237	NULL
bp	NULL
shorter	NULL
than	NULL
that	NULL
of	NULL
K562	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
5'-terminal	NULL
28-bp	NULL
sequence	NULL
was	NULL
not	NULL
present	NULL
in	NULL
the	NULL
K562	NULL
cDNA	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
genomic	NULL
sequence	NULL
of	NULL
RALDH2	NULL
revealed	NULL
that	NULL
the	NULL
28-bp	NULL
sequence	NULL
was	NULL
derived	NULL
from	NULL
the	NULL
second	NULL
intron	NULL
.	NULL

All	NULL
of	NULL
the	NULL
clones	NULL
obtained	NULL
from	NULL
Molt4	NULL
cells	NULL
by	NULL
the	NULL
S'RACE	NULL
method	NULL
contained	NULL
the	NULL
same	NULL
short	NULL
5	NULL
'	NULL
portion	NULL
,	NULL
suggesting	NULL
that	NULL
transcription	NULL
was	NULL
initiated	NULL
from	NULL
a	NULL
cryptic	NULL
promoter	NULL
within	NULL
the	NULL
second	NULL
intron	NULL
of	NULL
the	NULL
RALDH2	NULL
gene	NULL
in	NULL
Moltd4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

This	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
primer	NULL
extension	NULL
analysis	NULL
and	NULL
RNase	NULL
protection	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
analyses	NULL
also	NULL
revealed	NULL
that	NULL
there	NULL
were	NULL
several	NULL
transcriptional	NULL
initiation	NULL
sites	NULL
within	NULL
~30	NULL
bp	NULL
around	NULL
the	NULL
boundary	NULL
between	NULL
the	NULL
second	NULL
intron	NULL
and	NULL
third	NULL
exon	NULL
of	NULL
the	NULL
RALDH2	NULL
gene	NULL
.	NULL

To	NULL
test	NULL
which	NULL
types	NULL
of	NULL
message	NULL
were	NULL
transcribed	NULL
in	NULL
other	NULL
T-ALL	NULL
cell	NULL
lines	NULL
,	NULL
RALDH2	NULL
transcription	NULL
was	NULL
examined	NULL
by	NULL
RT-PCR	NULL
with	NULL
primer	NULL
sets	NULL
specific	NULL
for	NULL
the	NULL
full-length	NULL
type	NULL
(	NULL
F1-R1	NULL
)	NULL
,	NULL
the	NULL
5'-truncated	NULL
type	NULL
(	NULL
F2-R1	NULL
)	NULL
,	NULL
or	NULL
both	NULL
(	NULL
F3-R1	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
K562	NULL
cells	NULL
expressed	NULL
only	NULL
the	NULL
full-length	NULL
type	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
although	NULL
some	NULL
full-length	NULL
type	NULL
messages	NULL
were	NULL
also	NULL
detected	NULL
in	NULL
Molt4	NULL
and	NULL
SALT12	NULL
cells	NULL
,	NULL
the	NULL
major	NULL
transcripts	NULL
in	NULL
T-ALL-derived	NULL
cell	NULL
lines	NULL
were	NULL
of	NULL
the	NULL
truncated	NULL
type	NULL
.	NULL

Furthermore	NULL
,	NULL
HPB-ALL	NULL
clones	NULL
stably	NULL
expressing	NULL
transfected	NULL
TAL1a	NULL
and	NULL
LMO1	NULL
also	NULL
expressed	NULL
only	NULL
the	NULL
truncated-type	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
ectopic	NULL
expression	NULL
of	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
induces	NULL
transcription	NULL
mostly	NULL
if	NULL
not	NULL
exclusively	NULL
from	NULL
the	NULL
intronic	NULL
promoter	NULL
of	NULL
the	NULL
RALDH2	NULL
gene	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
alternatively	NULL
initiated	NULL
type	NULL
of	NULL
mRNA	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
normal	NULL
human	NULL
tissues	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
type	NULL
of	NULL
mRNA	NULL
is	NULL
highly	NULL
specific	NULL
for	NULL
T-ALL	NULL
.	NULL

The	NULL
first	NULL
AUG	NULL
codon	NULL
of	NULL
T-ALL-specific	NULL
mRNA	NULL
is	NULL
in	NULL
the	NULL
same	NULL
frame	NULL
of	NULL
the	NULL
full-length	NULL
RALDH2	NULL
mRNA	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
former	NULL
encodes	NULL
an	NULL
N-terminally	NULL
truncated	NULL
protein	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
,	NULL
we	NULL
performed	NULL
in	NULL
vitro	NULL
translation	NULL
experiments	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
56	NULL
and	NULL
46-kDa	NULL
proteins	NULL
were	NULL
translated	NULL
from	NULL
the	NULL
full-length	NULL
mRNA	NULL
and	NULL
the	NULL
T-ALL-specific	NULL
mRNA	NULL
,	NULL
respectively	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
N-terminally	NULL
truncated	NULL
46-kDa	NULL
protein	NULL
is	NULL
produced	NULL
in	NULL
T-ALL	NULL
cells	NULL
.	NULL

We	NULL
thus	NULL
designated	NULL
this	NULL
N-terminally	NULL
truncated	NULL
form	NULL
RALDH2-T	NULL
(	NULL
T-ALL	NULL
type	NULL
)	NULL
.	NULL

A	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
mechanism	NULL
of	NULL
regulation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
containing	NULL
the	NULL
1.7-kb	NULL
genomic	NULL
fragment	NULL
upstream	NULL
of	NULL
the	NULL
first	NULL
ATG	NULL
codon	NULL
of	NULL
RALDH2-T	NULL
(	NULL
-1.7-luc	NULL
[	NULL
see	NULL
Fig	NULL
.	NULL

4A	NULL
]	NULL
)	NULL
and	NULL
transfected	NULL
it	NULL
with	NULL
or	NULL
without	NULL
TAL1	NULL
and	NULL
LMO	NULL
into	NULL
HPB-ALL	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
either	NULL
TAL1	NULL
or	NULL
LMO	NULL
alone	NULL
did	NULL
not	NULL
induce	NULL
the	NULL
transcription	NULL
from	NULL
the	NULL
reporter	NULL
.	NULL

However	NULL
,	NULL
TAL1	NULL
and	NULL
LMO1	NULL
or	NULL
LMO2	NULL
transactivated	NULL
the	NULL
reporter	NULL
18-	NULL
and	NULL
8-fold	NULL
,	NULL
respectively	NULL
.	NULL

TAL1la	NULL
and	NULL
TAL1B	NULL
had	NULL
similar	NULL
activities	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

These	NULL
results	NULL
were	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
endogeneous	NULL
RALDH2-T	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
1.7-kb	NULL
genomic	NULL
fragment	NULL
contains	NULL
a	NULL
regulatory	NULL
element	NULL
(	NULL
s	NULL
)	NULL
responsible	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
RALDH2-T	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
a	NULL
TATA	NULL
box-like	NULL
sequence	NULL
is	NULL
not	NULL
seen	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
,	NULL
but	NULL
the	NULL
major	NULL
initiation	NULL
site	NULL
matches	NULL
the	NULL
consensus	NULL
initiator	NULL
(	NULL
Inr	NULL
)	NULL
sequence	NULL
(	NULL
24	NULL
)	NULL
.	NULL

There	NULL
are	NULL
an	NULL
E-box	NULL
(	NULL
CAGGTG	NULL
)	NULL
known	NULL
to	NULL
be	NULL
recognized	NULL
by	NULL
TAL1-E2A	NULL
heterodimers	NULL
(	NULL
60	NULL
)	NULL
at	NULL
position	NULL
-273	NULL
(	NULL
ATG	NULL
is	NULL
+1	NULL
)	NULL
and	NULL
a	NULL
consensus	NULL
GATA	NULL
site	NULL
(	NULL
AGATAA	NULL
)	NULL
(	NULL
29	NULL
,	NULL
37	NULL
)	NULL
at	NULL
position	NULL
-239	NULL
.	NULL

To	NULL
identify	NULL
responsive	NULL
elements	NULL
in	NULL
the	NULL
RALDH2-T	NULL
pro	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Full	NULL
T-ALL	NULL
Full	NULL
LJ	NULL
.	NULL
'	NULL

.	NULL

&	NULL
lt	NULL
U	NULL
(	NULL
G	NULL
U	NULL
|	NULL
Mk	NULL
wads	NULL
dln	NULL
F1	NULL
F3	NULL
R1	NULL
T-ALL	NULL
yella	NULL
C	NULL
rod	NULL
_	NULL
those	NULL
F2	NULL
F3	NULL
R1	NULL
E	NULL
15	NULL
as	NULL
o	NULL
Ml	NULL
5a	NULL
f	NULL
$	NULL
f	NULL
3	NULL
5	NULL
§	NULL
§	NULL
§	NULL
§	NULL
&	NULL
lu	NULL
PJ	NULL
©	NULL
y	NULL
\	NULL
wom	NULL
«	NULL
-d	NULL
-	NULL
]	NULL
``	NULL
i	NULL
Full	NULL
97	NULL
667	NULL
457	NULL
314	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Structures	NULL
of	NULL
the	NULL
RALDH2	NULL
gene	NULL
and	NULL
mRNA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Schematic	NULL
illustration	NULL
of	NULL
the	NULL
RALDH2	NULL
gene	NULL
.	NULL

Boxes	NULL
and	NULL
lines	NULL
correspond	NULL
to	NULL
exons	NULL
and	NULL
introns	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
transcription	NULL
start	NULL
sites	NULL
of	NULL
the	NULL
full-length	NULL
RALDH2	NULL
and	NULL
the	NULL
T-ALL-type	NULL
RALDH2	NULL
(	NULL
RALDH2-T	NULL
)	NULL
are	NULL
marked	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
5	NULL
'	NULL
structure	NULL
of	NULL
RALDH2	NULL
mRNA	NULL
in	NULL
T-ALL	NULL
cell	NULL
lines	NULL
.	NULL

Two	NULL
types	NULL
of	NULL
RALDH2Z	NULL
cDNA	NULL
and	NULL
the	NULL
positions	NULL
of	NULL
primers	NULL
used	NULL
for	NULL
RT-PCR	NULL
to	NULL
distinguish	NULL
each	NULL
type	NULL
are	NULL
shown	NULL
schematically	NULL
at	NULL
the	NULL
top	NULL
.	NULL

Total	NULL
RNA	NULL
samples	NULL
prepared	NULL
from	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
were	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
.	NULL

Amplification	NULL
products	NULL
were	NULL
electrophoresed	NULL
on	NULL
2	NULL
%	NULL
agarose	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Two	NULL
clones	NULL
were	NULL
analyzed	NULL
for	NULL
HPB-ALL	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
TAL1a	NULL
and	NULL
LMO1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
In	NULL
vitro	NULL
translation	NULL
from	NULL
two	NULL
types	NULL
of	NULL
RALDH2	NULL
mRNA	NULL
.	NULL

Both	NULL
types	NULL
of	NULL
RALDH2	NULL
cDNA	NULL
were	NULL
transcribed	NULL
in	NULL
vitro	NULL
and	NULL
translated	NULL
in	NULL
rabbit	NULL
reticulocyte	NULL
lysate	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
*SJmethionine	NULL
.	NULL

Translation	NULL
products	NULL
were	NULL
analyzed	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
and	NULL
autoradiography	NULL
.	NULL

Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
GCCCAAGGGA	NULL
AGAGGTGATC	NULL
CCATTCTGTT	NULL
ATCTACTCCC	NULL
TTAGATCTTT	NULL
-343	NULL
exon2	NULL
[	NULL
ATAAACRACG	NULL
AGTGGCAGAR	NULL
CTCRGAGAGT	NULL
cecAchcter	NULL
-293	NULL
[	NULL
TAATCCAGCC	NULL
ACAGGAGAAC	NULL
AGGTGTGTGA	NULL
AGTTCAAGAA	NULL
GCAGACAAGG	NULL
<	NULL
243	NULL
E-box	NULL
TATGTCTTTT	NULL
GTAGATAAAA	NULL
GATTTCCTAT	NULL
GAAATAACTG	NULL
CCTTCAAACA	NULL
-193	NULL
GATA	NULL
site	NULL
GCAGAGCAGC	NULL
AAACATATGC	NULL
TCTCAGTACA	NULL
CCACTACATG	NULL
CTCATecTTc	NULL
-143	NULL
r*	NULL
r*	NULL
ACTTTTTTCA	NULL
TGACAGTGGA	NULL
TEGTTCTTCC	NULL
TPTATTTGGA	NULL
GTGTTTTTCT	NULL
-as	NULL
re	NULL
re	NULL
TCAGTTGTGC	NULL
CTCTTCCTCT	NULL
CTAACAGGCA	NULL
GATATAGACA	NULL
AAGCAGTGCA	NULL
~43	NULL
+1	NULL
eecaccoosc	NULL
CTeecTTTcT	NULL
CTCTTecTTc	NULL
AcTGorecaca	NULL
AGGATGGATGI	NULL
+7	NULL
exon3	NULL
[	NULL
efTcaGcaars	NULL
cocaceTcTe	NULL
TIGGATAAGC	NULL
_	NULL
TTGCAGACTT	NULL
GGTGGAACGG	NULL
]	NULL
+57	NULL
GACAGGGCAG	NULL
TTCTTGCAGT	NULL
AAGTAACCTA	NULL
AGAAAACATT	NULL
AAGTCTTTAA	NULL
+107	NULL
HPB-ALL	NULL
>	NULL
=	NULL
&	NULL
0	NULL
*-8	NULL
$	NULL
$	NULL
E	NULL
2	NULL
@	NULL
£0	NULL
10-7	NULL
H	NULL
e	NULL
TAL1	NULL
_	NULL
O0	NULL
-	NULL
-	NULL
TALfG	NULL
TALfG	NULL
TALfc	NULL
TAL1B	NULL
TAL1B	NULL
TAL1B	NULL
LMO	NULL
-_	NULL
LMO1	NULL
LMO2	NULL
--	NULL
LMO1	NULL
LMO2	NULL
-	NULL
LMO1	NULL
LMoz	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nucleotide	NULL
sequence	NULL
around	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
RALDH2-T.	NULL
Exon	NULL
sequences	NULL
are	NULL
boxed	NULL
.	NULL

A	NULL
consensus	NULL
GATA	NULL
site	NULL
,	NULL
an	NULL
optimal	NULL
E-box	NULL
,	NULL
and	NULL
the	NULL
putative	NULL
initiation	NULL
codon	NULL
of	NULL
RALDH2-T	NULL
are	NULL
underlined	NULL
.	NULL

Major	NULL
transcriptional	NULL
initiation	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

(	NULL
B	NULL
)	NULL
HPB-ALL	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
20	NULL
ug	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
plasmid	NULL
containing	NULL
the	NULL
1.7-kb	NULL
genomic	NULL
fragment	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
(	NULL
-1.7-luc	NULL
)	NULL
,	NULL
0.1	NULL
pg	NULL
of	NULL
pRL-CMV	NULL
for	NULL
normalization	NULL
of	NULL
transfection	NULL
efficiency	NULL
,	NULL
and	NULL
5	NULL
pg	NULL
each	NULL
of	NULL
expression	NULL
plasmids	NULL
without	NULL
inserts	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
the	NULL
indicated	NULL
inserts	NULL
.	NULL

Relative	NULL
luciferase	NULL
activity	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
the	NULL
reporter	NULL
plasmid	NULL
alone	NULL
was	NULL
determined	NULL
.	NULL

Means	NULL
and	NULL
standard	NULL
deviations	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

moter	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
series	NULL
of	NULL
5	NULL
'	NULL
deletion	NULL
mutants	NULL
and	NULL
examined	NULL
activation	NULL
of	NULL
these	NULL
reporters	NULL
by	NULL
TAL1	NULL
«	NULL
and	NULL
LMO1	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Unexpectedly	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
E-box	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
response	NULL
(	NULL
compare	NULL
-308-luc	NULL
with	NULL
-267-luc	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
E-box	NULL
also	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
transcription	NULL
from	NULL
the	NULL
reporter	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
deletion	NULL
removing	NULL
3	NULL
bases	NULL
in	NULL
the	NULL
GATA	NULL
site	NULL
abrogated	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
reporter	NULL
by	NULL
TAL1	NULL
«	NULL
and	NULL
LMO1	NULL
(	NULL
compare	NULL
-231-luc	NULL
with	NULL
-228-luc	NULL
)	NULL
.	NULL

Further	NULL
deletions	NULL
to	NULL
position	NULL
-142	NULL
(	NULL
~50	NULL
bp	NULL
upstream	NULL
of	NULL
transcription	NULL
start	NULL
sites	NULL
)	NULL
and	NULL
the	NULL
deletion	NULL
downstream	NULL
of	NULL
the	NULL
start	NULL
site	NULL
had	NULL
little	NULL
further	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
specifically	NULL
address	NULL
the	NULL
role	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
at	NULL
position	NULL
-239	NULL
,	NULL
this	NULL
element	NULL
was	NULL
changed	NULL
to	NULL
a	NULL
restriction	NULL
site	NULL
(	NULL
-1.7GM-luc	NULL
[	NULL
Fig	NULL
.	NULL

4BJ	NULL
)	NULL
.	NULL

The	NULL
mutation	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
effectively	NULL
abrogated	NULL
the	NULL
response	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
indicate	NULL
that	NULL
the	NULL
GATA	NULL
site	NULL
at	NULL
position	NULL
-239	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
is	NULL
essential	NULL
for	NULL
induction	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

INDUCTION	NULL
OF	NULL
RALDH2	NULL
BY	NULL
TALl	NULL
AND	NULL
LMO	NULL
IN	NULL
T-ALL	NULL
-	NULL
6943	NULL
GATA3	NULL
is	NULL
involved	NULL
in	NULL
induction	NULL
of	NULL
R4LDH2-T	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
HPB-ALL	NULL
cells	NULL
and	NULL
used	NULL
for	NULL
EMSA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
binding	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
was	NULL
observed	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
competed	NULL
out	NULL
by	NULL
a	NULL
200-fold	NULL
excess	NULL
of	NULL
the	NULL
same	NULL
cold	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
the	NULL
mutant	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
GATA	NULL
mutant	NULL
reporter	NULL
(	NULL
-1.7GM-luc	NULL
[	NULL
Fig	NULL
.	NULL

4B	NULL
]	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
binding	NULL
was	NULL
specific	NULL
for	NULL
the	NULL
GATA	NULL
site	NULL
.	NULL

The	NULL
binding	NULL
was	NULL
also	NULL
competed	NULL
out	NULL
by	NULL
the	NULL
T-cell	NULL
receptor	NULL
alpha	NULL
(	NULL
TCRa	NULL
)	NULL
GATA	NULL
site	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
binding	NULL
protein	NULL
is	NULL
a	NULL
GATA-binding	NULL
protein	NULL
family	NULL
member	NULL
.	NULL

Among	NULL
six	NULL
members	NULL
identified	NULL
in	NULL
the	NULL
GATA-binding	NULL
protein	NULL
family	NULL
,	NULL
only	NULL
GATA3	NULL
is	NULL
known	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
the	NULL
T-cell	NULL
lineage	NULL
(	NULL
19	NULL
,	NULL
28	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
used	NULL
an	NULL
anti-GATA3	NULL
MAb	NULL
for	NULL
supershift	NULL
experiments	NULL
.	NULL

The	NULL
anti-GATA3	NULL
MAb	NULL
indeed	NULL
supershifted	NULL
the	NULL
binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
binding	NULL
protein	NULL
is	NULL
GATA3	NULL
.	NULL

The	NULL
same	NULL
shift	NULL
band	NULL
was	NULL
observed	NULL
even	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
an	NULL
HPB-ALL	NULL
clone	NULL
stably	NULL
expressing	NULL
TALla	NULL
and	NULL
LMO1	NULL
,	NULL
suggesting	NULL
that	NULL
TAL1a	NULL
and	NULL
LMO1	NULL
did	NULL
not	NULL
directly	NULL
bind	NULL
to	NULL
this	NULL
site	NULL
and	NULL
that	NULL
the	NULL
binding	NULL
of	NULL
GATA3	NULL
to	NULL
this	NULL
site	NULL
was	NULL
not	NULL
appreciably	NULL
enhanced	NULL
by	NULL
TAL1a	NULL
«	NULL
and	NULL
LMO1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Next	NULL
we	NULL
examined	NULL
whether	NULL
overexpression	NULL
of	NULL
GATA3	NULL
could	NULL
affect	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5E	NULL
,	NULL
overexpression	NULL
of	NULL
GATA3	NULL
alone	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
did	NULL
not	NULL
enhance	NULL
-1.7-luc	NULL
reporter	NULL
expression	NULL
.	NULL

However	NULL
,	NULL
its	NULL
induction	NULL
by	NULL
TAL1	NULL
«	NULL
and	NULL
LMO	NULL
was	NULL
further	NULL
up-regulated	NULL
by	NULL
overexpression	NULL
of	NULL
GATA3	NULL
,	NULL
especially	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
TAL1	NULL
«	NULL
and	NULL
LMO2	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
dominant	NULL
negative	NULL
GATA3	NULL
(	NULL
KRR	NULL
)	NULL
(	NULL
53	NULL
)	NULL
effectively	NULL
suppressed	NULL
induction	NULL
of	NULL
the	NULL
reporter	NULL
by	NULL
TAL1a	NULL
«	NULL
and	NULL
LMO	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
support	NULL
the	NULL
idea	NULL
that	NULL
GATA3	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

This	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
the	NULL
same	NULL
transfection	NULL
assays	NULL
with	NULL
a	NULL
B-ALL-derived	NULL
cell	NULL
line	NULL
,	NULL
BALL-1	NULL
(	NULL
54	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5F	NULL
)	NULL
.	NULL

We	NULL
confirmed	NULL
by	NULL
RT-PCR	NULL
that	NULL
BALL-1	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
TAL1	NULL
,	NULL
LMO1	NULL
,	NULL
LMO2	NULL
,	NULL
or	NULL
GATA3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
-1.7-luc	NULL
reporter	NULL
gene	NULL
was	NULL
not	NULL
activated	NULL
even	NULL
by	NULL
cotransfection	NULL
of	NULL
TAL1la	NULL
«	NULL
and	NULL
LMO	NULL
.	NULL

GATA3	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
either	NULL
.	NULL

However	NULL
,	NULL
cotransfection	NULL
of	NULL
GATA3	NULL
,	NULL
TAL1la	NULL
,	NULL
and	NULL
LMO	NULL
activated	NULL
the	NULL
reporter	NULL
by	NULL
~20-fold	NULL
.	NULL

This	NULL
further	NULL
supports	NULL
the	NULL
idea	NULL
that	NULL
GATA3	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

These	NULL
results	NULL
led	NULL
us	NULL
to	NULL
examine	NULL
the	NULL
physical	NULL
interactions	NULL
between	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
.	NULL

TAL1	NULL
had	NULL
been	NULL
reported	NULL
to	NULL
interact	NULL
with	NULL
LMO	NULL
in	NULL
vivo	NULL
(	NULL
56	NULL
,	NULL
59	NULL
)	NULL
.	NULL

This	NULL
was	NULL
also	NULL
confirmed	NULL
by	NULL
our	NULL
experiments	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

FLAG-tagged	NULL
GATA3	NULL
and	NULL
HA-tagged	NULL
LMO1	NULL
or	NULL
LMO2	NULL
were	NULL
transiently	NULL
expressed	NULL
in	NULL
293E	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
HA-LMO1	NULL
as	NULL
well	NULL
as	NULL
HA-LMO2	NULL
was	NULL
coimmunoprecipitated	NULL
with	NULL
FLAG-GATA3	NULL
from	NULL
the	NULL
cell	NULL
lysates	NULL
by	NULL
an	NULL
anti-FLAG	NULL
MAb	NULL
,	NULL
suggesting	NULL
that	NULL
both	NULL
LMO1	NULL
and	NULL
LMO2	NULL
were	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
GATA3	NULL
in	NULL
vivo	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
direct	NULL
interaction	NULL
between	NULL
TAL1B	NULL
and	NULL
GATA3	NULL
was	NULL
not	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMO2	NULL
,	NULL
HA-TAL1B	NULL
was	NULL
coimmunoprecipitated	NULL
with	NULL
FLAG-GATA3	NULL
,	NULL
suggesting	NULL
that	NULL
LMO2	NULL
is	NULL
capable	NULL
of	NULL
bridging	NULL
TAL1	NULL
and	NULL
GATA3	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
observations	NULL
strongly	NULL
suggest	NULL
that	NULL
a	NULL
complex	NULL
consisting	NULL
of	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
is	NULL
formed	NULL
in	NULL
T-ALL	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
complex	NULL
induces	NULL
transcription	NULL
from	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

DNA	NULL
binding	NULL
activity	NULL
of	NULL
GATA3	NULL
is	NULL
required	NULL
for	NULL
transactivation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

Thus	NULL
far	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
a	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
induction	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
and	NULL
that	NULL
GATA3	NULL
acts	NULL
in	NULL
collab-	NULL
6944	NULL
ONO	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

ATG	NULL
CC-	NULL
)	NULL
J-4	NULL
4p	NULL
37.	NULL
rr—aH	NULL
E-box	NULL
GATA	NULL
-1.7-lue	NULL
+/-	NULL
{	NULL
fuciferase	NULL
]	NULL
-308-luc	NULL
-267-luc	NULL
-231-luc	NULL
-228-luc	NULL
A181-luc	NULL
~142-lue	NULL
~1.7GM-luc	NULL
/n	NULL
-¥6	NULL
i	NULL
luciferasel	NULL
10	NULL
20	NULL
Fold	NULL
Activation	NULL
-1.7-lue	NULL
TCTCTTTTCTAGATAAAACGATTTCCT	NULL
v	NULL
TTY	NULL
T	NULL
-1.7GM-lue	NULL
TCTAG	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Requirement	NULL
of	NULL
a	NULL
GATA	NULL
site	NULL
but	NULL
not	NULL
an	NULL
E-box	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
for	NULL
induction	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HPB-ALL	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
one	NULL
of	NULL
the	NULL
indicated	NULL
RALDH2-T	NULL
reporter	NULL
plasmids	NULL
and	NULL
expression	NULL
vectors	NULL
for	NULL
TAL1	NULL
«	NULL
and	NULL
LMO1	NULL
.	NULL

The	NULL
results	NULL
show	NULL
fold	NULL
activation	NULL
in	NULL
luciferase	NULL
activity	NULL
from	NULL
the	NULL
reporter	NULL
alone	NULL
.	NULL

Means	NULL
and	NULL
standard	NULL
deviations	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Mutations	NULL
introduced	NULL
in	NULL
-1.7GM-luc	NULL
.	NULL

oration	NULL
with	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
next	NULL
tested	NULL
whether	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
GATA3	NULL
was	NULL
necessary	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
GATA3	NULL
mutant	NULL
lacking	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

In	NULL
the	NULL
case	NULL
of	NULL
GATA1	NULL
,	NULL
the	NULL
C-terminal	NULL
Zn	NULL
finger	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
and	NULL
a	NULL
mutant	NULL
with	NULL
cysteines	NULL
in	NULL
this	NULL
region	NULL
changed	NULL
to	NULL
glycines	NULL
could	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
but	NULL
still	NULL
interacted	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
SP1	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Like	NULL
this	NULL
GATA1	NULL
mutant	NULL
,	NULL
the	NULL
C-terminal	NULL
Zn	NULL
finger	NULL
of	NULL
GATA3	NULL
was	NULL
mutated	NULL
to	NULL
generate	NULL
GATA3-CFM	NULL
.	NULL

Whole-cell	NULL
lysates	NULL
of	NULL
COS	NULL
cells	NULL
transiently	NULL
expressing	NULL
FLAG-GATA3	NULL
or	NULL
FLAG-GATA3-CFM	NULL
were	NULL
used	NULL
for	NULL
EMSA	NULL
to	NULL
test	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
FLAG-GATA3	NULL
bound	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
of	NULL
the	NULL
TCRa	NULL
enhancer	NULL
region	NULL
(	NULL
19	NULL
)	NULL
and	NULL
was	NULL
supershifted	NULL
by	NULL
the	NULL
anti-FLAG	NULL
MAb	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
FLAG-GATA3-CFM	NULL
could	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
oligonucleotide	NULL
even	NULL
though	NULL
proteins	NULL
were	NULL
detected	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

It	NULL
was	NULL
also	NULL
demonstrated	NULL
that	NULL
GATA3-CFM	NULL
interacted	NULL
with	NULL
LMO2	NULL
in	NULL
vivo	NULL
by	NULL
coprecipitation	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
that	NULL
GATA3-CFM	NULL
could	NULL
form	NULL
a	NULL
complex	NULL
with	NULL
TAL1	NULL
and	NULL
LMO	NULL
but	NULL
could	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
.	NULL

After	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
GATA3-CFM	NULL
was	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
in	NULL
collaboration	NULL
with	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

When	NULL
GATA3-CFM	NULL
was	NULL
transfected	NULL
with	NULL
TAL1a	NULL
and	NULL
LMO	NULL
,	NULL
it	NULL
did	NULL
not	NULL
enhance	NULL
the	NULL
transcription	NULL
from	NULL
the	NULL
reporter	NULL
-1.7-lue	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
or	NULL
induce	NULL
the	NULL
transcription	NULL
in	NULL
BALL-1	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
GATA3	NULL
is	NULL
necessary	NULL
for	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
the	NULL
complex	NULL
containing	NULL
GATA3	NULL
,	NULL
TAL1	NULL
,	NULL
and	NULL
LMO	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
TAL1	NULL
is	NULL
dispensable	NULL
for	NULL
induction	NULL
of	NULL
RALDH2-T.	NULL
Next	NULL
we	NULL
tested	NULL
whether	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
TAL1	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

The	NULL
basic	NULL
region	NULL
of	NULL
bHLH-type	NULL
transcription	NULL
factors	NULL
is	NULL
known	NULL
to	NULL
be	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
(	NULL
8	NULL
,	NULL
11	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
mutated	NULL
three	NULL
amino	NULL
acids	NULL
,	NULL
in	NULL
the	NULL
basic	NULL
region	NULL
,	NULL
RRR	NULL
,	NULL
which	NULL
are	NULL
highly	NULL
conserved	NULL
in	NULL
various	NULL
bHLH	NULL
proteins	NULL
(	NULL
40	NULL
)	NULL
,	NULL
to	NULL
ala-nines	NULL
(	NULL
AAA	NULL
)	NULL
and	NULL
designated	NULL
this	NULL
mutant	NULL
TAL1B-BM	NULL
(	NULL
for	NULL
basic	NULL
region	NULL
mutant	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
TAL1B-BM	NULL
could	NULL
still	NULL
interact	NULL
with	NULL
E47	NULL
,	NULL
a	NULL
partner	NULL
of	NULL
the	NULL
heterodimer	NULL
,	NULL
or	NULL
with	NULL
LMO	NULL
,	NULL
coprecipitation	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
HA-tagged	NULL
E47S	NULL
was	NULL
coprecipitated	NULL
with	NULL
FLAG-TAL1fB-BM	NULL
as	NULL
well	NULL
as	NULL
with	NULL
wild-type	NULL
FLAG-TAL1B	NULL
.	NULL

HA-tagged	NULL
LMO2	NULL
was	NULL
also	NULL
coprecipitated	NULL
with	NULL
FLAG-TAL1B-BM	NULL
,	NULL
although	NULL
the	NULL
interaction	NULL
appeared	NULL
to	NULL
be	NULL
weaker	NULL
than	NULL
that	NULL
of	NULL
LMO2	NULL
and	NULL
wild-type	NULL
TAL1f	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirmed	NULL
that	NULL
TAL1BBM	NULL
was	NULL
still	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
E47	NULL
and	NULL
LMO2	NULL
.	NULL

Next	NULL
we	NULL
examined	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
TAL1B-BM	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
,	NULL
binding	NULL
to	NULL
the	NULL
consensus	NULL
E-box	NULL
(	NULL
21	NULL
)	NULL
by	NULL
the	NULL
lysate	NULL
of	NULL
293E	NULL
cells	NULL
expressing	NULL
both	NULL
FLAG-TAL1B	NULL
and	NULL
HA-E47S	NULL
was	NULL
observed	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
inhibited	NULL
by	NULL
addition	NULL
of	NULL
anti-FLAG	NULL
MAb	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
complex	NULL
contained	NULL
FLAG-TAL1f	NULL
.	NULL

The	NULL
binding	NULL
was	NULL
competed	NULL
out	NULL
by	NULL
addition	NULL
of	NULL
the	NULL
cold	NULL
E-box	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
the	NULL
cold	NULL
GATA	NULL
site	NULL
oligonucleo-tide	NULL
,	NULL
confirming	NULL
that	NULL
the	NULL
TAL1-E47	NULL
heterodimer	NULL
was	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
consensus	NULL
E-box	NULL
but	NULL
not	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
specific	NULL
binding	NULL
by	NULL
the	NULL
lysate	NULL
of	NULL
293E	NULL
cells	NULL
expressing	NULL
FLAG-TAL1B-BM	NULL
and	NULL
HA-EATS	NULL
was	NULL
observed	NULL
,	NULL
even	NULL
though	NULL
the	NULL
protein	NULL
expression	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

These	NULL
results	NULL
indicated	NULL
that	NULL
TAL1B-BM	NULL
was	NULL
capable	NULL
of	NULL
forming	NULL
a	NULL
heterodimer	NULL
with	NULL
EA47S	NULL
but	NULL
that	NULL
the	NULL
resulting	NULL
dimer	NULL
did	NULL
not	NULL
efficiently	NULL
bind	NULL
to	NULL
DNA	NULL
.	NULL

After	NULL
these	NULL
experiments	NULL
,	NULL
we	NULL
examined	NULL
whether	NULL
TAL1B-BM	NULL
was	NULL
still	NULL
capable	NULL
of	NULL
inducing	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
in	NULL
collaboration	NULL
with	NULL
LMO	NULL
and	NULL
GATA3	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
TAL1B-BM	NULL
induced	NULL
the	NULL
transcription	NULL
from	NULL
the	NULL
RALDHZ-T	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
INDUCTION	NULL
OF	NULL
RALDH2	NULL
BY	NULL
TALl	NULL
AND	NULL
LMO	NULL
IN	NULL
T-ALL	NULL
_	NULL
6945	NULL
HPB-ALL	NULL
N.E	NULL
.	NULL

cold	NULL
RALDH2-GATA	NULL
-	NULL
i-	NULL
i	NULL
1-	NULL
i-	NULL
t	NULL
i-	NULL
FLAG-GATA3	NULL
-	NULL
WTCFMWT	NULL
wT	NULL
wT	NULL
cold	NULL
RALDH2-GATA	NULL
M	NULL
-	NULL
-	NULL
-	NULL
$	NULL
f	NULL
-	NULL
-	NULL
-	NULL
cold	NULL
GATA	NULL
-	NULL
-	NULL
-	NULL
-	NULL
cold	NULL
TCR-GATA	NULL
-	NULL
-	NULL
-	NULL
-	NULL
$	NULL
-	NULL
-	NULL
cold	NULL
E-box	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
cold	NULL
E-bOx	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
$	NULL
-	NULL
anti-FLAG	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
+	NULL
anti-GATA3	NULL
-	NULL
-	NULL
-	NULL
-o-	NULL
-	NULL
+	NULL
supershift	NULL
-	NULL
»	NULL
supershift	NULL
-	NULL
»	NULL
GATA3	NULL
-	NULL
»	NULL
GATA3	NULL
-	NULL
»	NULL
w	NULL
:	NULL
artag	NULL
[	NULL
_	NULL
~	NULL
,	NULL
wal+catas	NULL
Gat	NULL
,	NULL
wires	NULL
FLAG-GATA3	NULL
+	NULL
+	NULL
FLAG-GATA3	NULL
-+	NULL
FLAG-GATA3	NULL
-	NULL
WTCFM	NULL
HA-TAL1B	NULL
+	NULL
+	NULL
HA-LMO1	NULL
4+	NULL
+	NULL
HA-LMO2	NULL
+	NULL
+	NULL
+	NULL
LMO2	NULL
-+	NULL
wo	NULL
-	NULL
[	NULL
_-	NULL
]	NULL
hawo	NULL
00	NULL
-	NULL
<	NULL
was	NULL
nde	NULL
ore	NULL
W:0HA	NULL
W	NULL
:	NULL
OHA	NULL
TAL1B—	NULL
>	NULL
W	NULL
:	NULL
OHA	NULL
*	NULL
IP	NULL
:	NULL
QFLAG	NULL
*	NULL
)	NULL
|	NULL
IP	NULL
:	NULL
aFLAG	NULL
%	NULL
;	NULL
-	NULL
»	NULL
U	NULL
IP:0FLAG	NULL
Lysate	NULL
-	NULL
»	NULL
Lysate	NULL
Lysate	NULL
HPB-ALL	NULL
BALL-1	NULL
174ue	NULL
30	NULL
-	NULL
+1.7-lue	NULL
&	NULL
20-3	NULL
o	NULL
€	NULL
§	NULL
€	NULL
P	NULL
E	NULL
8	NULL
20	NULL
€	NULL
8	NULL
®	NULL
'	NULL
o	NULL
€	NULL
104	NULL
2	NULL
*	NULL
o	NULL
G	NULL
£	NULL
~	NULL
®	NULL
107	NULL
l	NULL
TAL1I®M	NULL
-	NULL
o-	NULL
o-	NULL
o-	NULL
of	NULL
oto	NULL
oto	NULL
of	NULL
obo	NULL
ot	NULL
+o	NULL
TANG	NULL
k	NULL
ok	NULL
op	NULL
ofp	NULL
ogee	NULL
fo	NULL
oto	NULL
boob	NULL
#	NULL
LMO	NULL
_-	NULL
_	NULL
.	NULL

_-	NULL
-	NULL
LMO1	NULL
LMO1	NULL
LMO1	NULL
LMO1	NULL
LMO2	NULL
LMO2	NULL
LMO2	NULL
LMO2	NULL
LMO	NULL
_	NULL
_	NULL
_	NULL
_-	NULL
.	NULL

LMOT	NULL
LMO1	NULL
LMO1	NULL
LMO1	NULL
LMO2	NULL
LMO2	NULL
LMO2	NULL
LMO2	NULL
GATA3	NULL
|	NULL
-	NULL
WT	NULL
KAR	NULL
CFM	NULL
O-	NULL
WT	NULL
KRR	NULL
CFM	NULL
O-	NULL
-	NULL
WT	NULL
KRA	NULL
CFM	NULL
GATA3	NULL
_	NULL
-	NULL
WT	NULL
KRR	NULL
CFM	NULL
O-	NULL
WT	NULL
KAR	NULL
CFM	NULL
|	NULL
--	NULL
-	NULL
WT	NULL
KAR	NULL
CFM	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Involvement	NULL
of	NULL
GATA3	NULL
in	NULL
induction	NULL
of	NULL
R4LDFH2-T	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

(	NULL
A	NULL
)	NULL
GATA3	NULL
binds	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
HPB-ALL	NULL
cells	NULL
and	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

Cold	NULL
competitors	NULL
in	NULL
200-fold	NULL
excess	NULL
or	NULL
anti-GATA3	NULL
MAb	NULL
was	NULL
added	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
GATA3-CFM	NULL
mutant	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
.	NULL

COS	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
mutant	NULL
GATA3	NULL
expression	NULL
vectors	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
cell	NULL
lysates	NULL
from	NULL
transfected	NULL
COS	NULL
cells	NULL
and	NULL
a	NULL
labeled	NULL
oligonucleotide	NULL
spanning	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
TCRa	NULL
enhancer	NULL
.	NULL

Cold	NULL
competitors	NULL
in	NULL
200-fold	NULL
excess	NULL
or	NULL
anti-FLAG	NULL
MAb	NULL
was	NULL
added	NULL
as	NULL
indicated	NULL
.	NULL

Expression	NULL
of	NULL
GATA3	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
W	NULL
)	NULL
with	NULL
anti-FLAG	NULL
MAb	NULL
(	NULL
«	NULL
FLAG	NULL
)	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
nonspecific	NULL
binding	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Interaction	NULL
between	NULL
GATA3	NULL
and	NULL
LMO1	NULL
or	NULL
LMO2	NULL
in	NULL
vivo	NULL
.	NULL

Cell	NULL
lysates	NULL
from	NULL
293E	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
the	NULL
indicated	NULL
tagged	NULL
proteins	NULL
were	NULL
precipitated	NULL
with	NULL
anti-FLAG	NULL
MAb	NULL
.	NULL

Immunoprecipitates	NULL
(	NULL
IP	NULL
)	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-FLAG	NULL
or	NULL
anti-HA	NULL
MAb	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
immunoglobulin	NULL
H.	NULL
(	NULL
D	NULL
)	NULL
Complex	NULL
formation	NULL
between	NULL
TAL1	NULL
,	NULL
LMO2	NULL
,	NULL
and	NULL
GATA3	NULL
.	NULL

293E	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
FLAG-GATA3	NULL
and	NULL
HA-TAL1	NULL
with	NULL
or	NULL
without	NULL
that	NULL
for	NULL
LMO2	NULL
,	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
anti-FLAG	NULL
MAb	NULL
.	NULL

Immunoprecipitates	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
immunoblotted	NULL
with	NULL
anti-FLAG	NULL
or	NULL
anti-HA	NULL
MAb	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
immunoglobulin	NULL
H	NULL
or	NULL
L.	NULL
(	NULL
E	NULL
and	NULL
F	NULL
)	NULL
Effect	NULL
of	NULL
GATA3	NULL
on	NULL
induction	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

HPB-ALL	NULL
(	NULL
E	NULL
)	NULL
and	NULL
BALL-1	NULL
(	NULL
F	NULL
)	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
containing	NULL
the	NULL
1.7-kb	NULL
genomic	NULL
fragment	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
(	NULL
-1.7-luc	NULL
)	NULL
,	NULL
0.1	NULL
ug	NULL
of	NULL
pRL-CMV	NULL
for	NULL
normalization	NULL
of	NULL
transfection	NULL
efficiency	NULL
,	NULL
and	NULL
5	NULL
g	NULL
each	NULL
of	NULL
expression	NULL
plasmids	NULL
without	NULL
inserts	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
the	NULL
indicated	NULL
inserts	NULL
.	NULL

Relative	NULL
luciferase	NULL
activity	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
the	NULL
reporter	NULL
alone	NULL
was	NULL
determined	NULL
.	NULL

Means	NULL
and	NULL
standard	NULL
deviations	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

6946	NULL
ONO	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

FLAG-TAL1B	NULL
-	NULL
wT	NULL
BM	NULL
HA-E4rs	NULL
na-Ears	NULL
+++	NULL
FLAG-TALZB	NULL
-	NULL
£	NULL
\	NULL
;	NULL
V+TBMVTTVTTVTT	NULL
wm	NULL
!	NULL

mow	NULL
)	NULL
lows	NULL
!	NULL

mus	NULL
EA7S	NULL
-	NULL
»	NULL
IP	NULL
:	NULL
aFLAG	NULL
cold	NULL
E-box	NULL
--	NULL
W	NULL
:	NULL
oHA	NULL
cold	NULL
GATA	NULL
--	NULL
-	NULL
-	NULL
-	NULL
4	NULL
:	NULL
-	NULL
[	NULL
~-	NULL
2	NULL
,	NULL
gg	NULL
]	NULL
UFLA	NULL
~	NULL
«	NULL
!	NULL

-	NULL
<	NULL
<	NULL
-	NULL
-	NULL
+	NULL
TAL1B	NULL
-+-	NULL
w	NULL
:	NULL
aFLaAG	NULL
Lysate	NULL
~~~	NULL
dint	NULL
40	NULL
E47S	NULL
-	NULL
»	NULL
a	NULL
B	NULL
TAL1VEATS	NULL
-	NULL
»	NULL
FLAG-TAL1B	NULL
-	NULL
WT	NULL
BM	NULL
Hna-Lmo2	NULL
+	NULL
+	NULL
+	NULL
IP:0FLAG	NULL
LMO2	NULL
»	NULL
wee	NULL
*I	NULL
w	NULL
:	NULL
.aHaA	NULL
a	NULL
IP	NULL
:	NULL
aFLAG	NULL
maa	NULL
TAL1B	NULL
-|	NULL
_	NULL
MES	NULL
w.orag	NULL
W	NULL
:	NULL
aFLAG	NULL
Eﬁmuﬁ	NULL
Lysate	NULL
W	NULL
:	NULL
OHA	NULL
Eﬁ	NULL
E47S	NULL
Moe	NULL
|	NULL
|	NULL
w.oHA	NULL
to	NULL
BALL-1	NULL
HPB-ALL	NULL
#	NULL
+1.7-lue	NULL
Fl	NULL
+1.7-lue	NULL
g	NULL
B	NULL
g	NULL
&	NULL
20	NULL
8	NULL
3	NULL
§	NULL
tJ	NULL
£	NULL
5	NULL
o	NULL
$	NULL
1	NULL
3	NULL
10	NULL
3	NULL
$	NULL
$	NULL
®	NULL
$	NULL
°	NULL
G	NULL
a	NULL
$	NULL
TAL1B	NULL
-	NULL
_	NULL
wt	NULL
owt	NULL
sm	NULL
am	NULL
-	NULL
Bm	NULL
TAL1B	NULL
-	NULL
-	NULL
wr	NULL
owt	NULL
owT	NULL
o	NULL
wT	NULL
BM	NULL
-	NULL
BM	NULL
-	NULL
BM	NULL
-	NULL
BM	NULL
LMO	NULL
_	NULL
-	NULL
LMo1	NULL
LMO2	NULL
-	NULL
LMO1	NULL
LMO2	NULL
LMO	NULL
__	NULL
-	NULL
LMO1	NULL
LMO2	NULL
LMO1	NULL
LMO2	NULL
LMO1	NULL
LMO2	NULL
LMO1	NULL
LMO2	NULL
GATA	NULL
-	NULL
-o-	NULL
o	NULL
$	NULL
$	NULL
o	NULL
-o-	NULL
+o	NULL
+	NULL
TAL1B	NULL
-	NULL
TAL1B	NULL
BM	NULL
BM	NULL
__	NULL
TAL1B	NULL
Tau	NULL
_	NULL
_+	NULL
*	NULL
+	NULL
-	NULL
BM	NULL
LMO1	NULL
-	NULL
LMO2	NULL
-	NULL
LMO1	NULL
-__	NULL
C_	NULL
mn	NULL
.	NULL

mn	NULL
.	NULL

Cms	NULL
E2A	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

No	NULL
requirement	NULL
of	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
TAL1	NULL
for	NULL
induction	NULL
of	NULL
RALDF2-T.	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
TAL1B-BM	NULL
can	NULL
interact	NULL
with	NULL
E47	NULL
and	NULL
LMO2	NULL
.	NULL

Cell	NULL
lysates	NULL
from	NULL
293E	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
each	NULL
tagged	NULL
proteins	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
anti-FLAG	NULL
MAb	NULL
(	NULL
«	NULL
FLAG	NULL
)	NULL
.	NULL

Immunoprecipitates	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
immunoblotted	NULL
(	NULL
W	NULL
)	NULL
with	NULL
anti-FLAG	NULL
or	NULL
anti-HA	NULL
MAb	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
asterisk	NULL
indicates	NULL
immunoglobulin	NULL
L.	NULL
WT	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

(	NULL
C	NULL
)	NULL
TAL1B-BM	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
.	NULL

293E	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
expression	NULL
vectors	NULL
for	NULL
wild-type	NULL
or	NULL
mutant	NULL
TAL1B	NULL
and	NULL
E47S	NULL
.	NULL

EMSA	NULL
was	NULL
carried	NULL
out	NULL
by	NULL
using	NULL
cell	NULL
lysates	NULL
from	NULL
transfected	NULL
293E	NULL
cells	NULL
and	NULL
the	NULL
labeled	NULL
consensus	NULL
E-box	NULL
oligonucleotide	NULL
.	NULL

Cold	NULL
competitors	NULL
in	NULL
200-fold	NULL
excess	NULL
or	NULL
anti-FLAG	NULL
MAb	NULL
was	NULL
added	NULL
as	NULL
indicated	NULL
.	NULL

Expression	NULL
of	NULL
TAL1B	NULL
and	NULL
EA47S	NULL
was	NULL
confirmed	NULL
by	NULL
Western	NULL
blotting	NULL
with	NULL
anti-FLAG	NULL
MAb	NULL
.	NULL

Asterisks	NULL
indicate	NULL
nonspecific	NULL
binding	NULL
.	NULL

(	NULL
D	NULL
and	NULL
E	NULL
)	NULL
TAL1B-BM	NULL
induces	NULL
transcription	NULL
from	NULL
the	NULL
RALDH2-T	NULL
reporter	NULL
in	NULL
collaboration	NULL
with	NULL
LMO	NULL
and	NULL
GATA3	NULL
.	NULL

HPB-ALL	NULL
(	NULL
D	NULL
)	NULL
and	NULL
BALL-1	NULL
(	NULL
E	NULL
)	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
20	NULL
ug	NULL
(	NULL
D	NULL
)	NULL
or	NULL
15	NULL
ug	NULL
(	NULL
E	NULL
)	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
containing	NULL
the	NULL
1.7-kb	NULL
genomic	NULL
fragment	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
(	NULL
-1.7-luc	NULL
)	NULL
,	NULL
0.1	NULL
ug	NULL
of	NULL
pRL-CMV	NULL
for	NULL
normalization	NULL
of	NULL
transfection	NULL
efficiency	NULL
,	NULL
and	NULL
5	NULL
pg	NULL
each	NULL
of	NULL
expression	NULL
plasmids	NULL
without	NULL
inserts	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
the	NULL
indicated	NULL
inserts	NULL
.	NULL

Relative	NULL
luciferase	NULL
activity	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
the	NULL
reporter	NULL
alone	NULL
was	NULL
determined	NULL
.	NULL

Means	NULL
and	NULL
standard	NULL
deviations	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
F	NULL
)	NULL
TAL1B-BM	NULL
induces	NULL
endogeneous	NULL
RALDH2-T	NULL
expression	NULL
with	NULL
LMO	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
.	NULL

HPB-ALL	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
15	NULL
pg	NULL
each	NULL
of	NULL
indicated	NULL
expression	NULL
vectors	NULL
and	NULL
1	NULL
g	NULL
of	NULL
pRC/CMV-luc	NULL
by	NULL
electroporation	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
prepared	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
subjected	NULL
to	NULL
RT-PCR	NULL
analysis	NULL
for	NULL
RALDH2	NULL
and	NULL
£24	NULL
(	NULL
control	NULL
)	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
total	NULL
RNA	NULL
used	NULL
were	NULL
10	NULL
,	NULL
2	NULL
,	NULL
and	NULL
0.4	NULL
ng	NULL
from	NULL
left	NULL
to	NULL
right	NULL
.	NULL

Amplification	NULL
products	NULL
were	NULL
electrophoresed	NULL
on	NULL
2	NULL
%	NULL
agarose	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Transfection	NULL
efficiency	NULL
was	NULL
tested	NULL
by	NULL
luciferase	NULL
assay	NULL
and	NULL
varied	NULL
within	NULL
threefold	NULL
.	NULL

Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
BALL-1	NULL
1207	NULL
2	NULL
2	NULL
F	NULL
©	NULL
90	NULL
@	NULL
a	NULL
&	NULL
£	NULL
o	NULL
3	NULL
v	NULL
597	NULL
E	NULL
B	NULL
<	NULL
B	NULL
30	NULL
TAL1B	NULL
-	NULL
-	NULL
wr	NULL
o-	NULL
wr	NULL
oBMo	NULL
owt	NULL
o-	NULL
o	NULL
wT	NULL
o-	NULL
wto	NULL
sw	NULL
owt	NULL
LMO	NULL
__	NULL
-	NULL
LMO1	NULL
-	NULL
LMO1	NULL
LMOt	NULL
LMO1	NULL
-	NULL
LMO1	NULL
-	NULL
LMOt	NULL
LMot	NULL
LMot	NULL
GATA3	NULL
|	NULL
-o	NULL
-o	NULL
WT	NULL
o	NULL
wT	NULL
wT	NULL
CFM	NULL
o-	NULL
0	NULL
-o	NULL
wT	NULL
wT	NULL
wT	NULL
crm	NULL
CE	NULL
{	NULL
fuciferass	NULL
)	NULL
]	NULL
tk-lue	NULL
GATA	NULL
X3	NULL
tk-luc	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Transactivation	NULL
of	NULL
an	NULL
artificial	NULL
reporter	NULL
consisting	NULL
of	NULL
three	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
by	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
.	NULL

BALL-1	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
15	NULL
ug	NULL
of	NULL
an	NULL
artificial	NULL
luciferase	NULL
reporter	NULL
(	NULL
GATAX3-tk-lue	NULL
or	NULL
tk-luc	NULL
)	NULL
,	NULL
0.1	NULL
pg	NULL
of	NULL
pRL-CMV	NULL
for	NULL
normalization	NULL
of	NULL
transfection	NULL
efficiency	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
each	NULL
of	NULL
expression	NULL
plasmids	NULL
without	NULL
inserts	NULL
(	NULL
-	NULL
)	NULL
or	NULL
with	NULL
the	NULL
indicated	NULL
inserts	NULL
.	NULL

tk-lue	NULL
contains	NULL
only	NULL
the	NULL
HSV	NULL
#	NULL
minimal	NULL
promoter	NULL
.	NULL

GATAX3-tk-luc	NULL
contains	NULL
three	NULL
copies	NULL
of	NULL
the	NULL
GATA	NULL
site	NULL
from	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
linked	NULL
to	NULL
the	NULL
minimal	NULL
HSV	NULL
i	NULL
promoter	NULL
.	NULL

Relative	NULL
luciferase	NULL
activity	NULL
compared	NULL
to	NULL
that	NULL
of	NULL
the	NULL
reporter	NULL
alone	NULL
was	NULL
determined	NULL
.	NULL

Means	NULL
and	NULL
standard	NULL
deviations	NULL
for	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

WT	NULL
,	NULL
wild	NULL
type	NULL
.	NULL

reporter	NULL
-1.7-luc	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMO1	NULL
or	NULL
LMO2	NULL
,	NULL
although	NULL
less	NULL
efficiently	NULL
than	NULL
the	NULL
wild-type	NULL
.	NULL

Simi-larly	NULL
,	NULL
TAL1B-BM	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMO	NULL
and	NULL
GATA3	NULL
activated	NULL
the	NULL
transcription	NULL
by	NULL
~10-fold	NULL
in	NULL
BALL-1	NULL
cells	NULL
,	NULL
as	NULL
TAL1B	NULL
did	NULL
(	NULL
Fig	NULL
.	NULL

6E	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
transiently	NULL
expressed	NULL
TAL1B-BM	NULL
and	NULL
LMO	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
endogeneous	NULL
RALDH2	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6F	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
demonstrated	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
TAL1	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
that	NULL
of	NULL
GATA3	NULL
,	NULL
is	NULL
not	NULL
necessary	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

Thus	NULL
,	NULL
TAL1	NULL
acts	NULL
as	NULL
a	NULL
cofactor	NULL
for	NULL
GATA3	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
activate	NULL
transcription	NULL
through	NULL
the	NULL
GATA	NULL
site	NULL
.	NULL

To	NULL
further	NULL
demonstrate	NULL
that	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
was	NULL
sufficient	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
transcription	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
,	NULL
it	NULL
was	NULL
tandemly	NULL
repeated	NULL
three	NULL
times	NULL
and	NULL
linked	NULL
to	NULL
a	NULL
heterolo-gous	NULL
HSV	NULL
#	NULL
k	NULL
minimal	NULL
promoter	NULL
(	NULL
36	NULL
)	NULL
,	NULL
making	NULL
GATAX3-tk-luc	NULL
.	NULL

This	NULL
reporter	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
into	NULL
BALL-1	NULL
cells	NULL
with	NULL
various	NULL
combinations	NULL
of	NULL
expression	NULL
plasmids	NULL
for	NULL
TAL1B	NULL
,	NULL
LMO1	NULL
,	NULL
GATA3	NULL
,	NULL
and	NULL
their	NULL
mutants	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
although	NULL
parental	NULL
tk-luec	NULL
weakly	NULL
responded	NULL
to	NULL
the	NULL
combination	NULL
of	NULL
TAL1B	NULL
,	NULL
LMO1	NULL
,	NULL
and	NULL
GATA3	NULL
,	NULL
GATAX3-tk-lue	NULL
was	NULL
further	NULL
activated	NULL
by	NULL
~7-fold	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
TAL1f	NULL
,	NULL
LMO1	NULL
,	NULL
and	NULL
GATA3	NULL
was	NULL
indeed	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
transcription	NULL
through	NULL
the	NULL
GATA	NULL
site	NULL
alone	NULL
.	NULL

As	NULL
the	NULL
case	NULL
of	NULL
-1.7-luc	NULL
,	NULL
the	NULL
transcription	NULL
from	NULL
GATAX3-tk-lue	NULL
was	NULL
activated	NULL
even	NULL
by	NULL
TAL1B-BM	NULL
in	NULL
collaboration	NULL
with	NULL
LMO1	NULL
and	NULL
GATA3	NULL
but	NULL
not	NULL
by	NULL
GATA3-CFM	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TAL1B	NULL
and	NULL
LMO1	NULL
.	NULL

These	NULL
results	NULL
further	NULL
demonstrate	NULL
that	NULL
TAL1	NULL
and	NULL
LMO	NULL
induce	NULL
the	NULL
transcription	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
through	NULL
the	NULL
GATA	NULL
site	NULL
at	NULL
position	NULL
-239	NULL
by	NULL
acting	NULL
as	NULL
cofactors	NULL
for	NULL
GATA3	NULL
.	NULL

INDUCTION	NULL
OF	NULL
RALDH2	NULL
BY	NULL
TALl	NULL
AND	NULL
LMO	NULL
IN	NULL
T-ALL	NULL
-	NULL
6947	NULL
DISCUSSION	NULL
We	NULL
have	NULL
identified	NULL
the	NULL
RALDH2	NULL
gene	NULL
as	NULL
a	NULL
transcriptional	NULL
target	NULL
gene	NULL
for	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
.	NULL

RALDH2	NULL
was	NULL
strongly	NULL
induced	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
upon	NULL
stable	NULL
as	NULL
well	NULL
as	NULL
transient	NULL
coexpression	NULL
of	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

Most	NULL
T-ALL-derived	NULL
cell	NULL
lines	NULL
that	NULL
ectopically	NULL
coexpress	NULL
TAL	NULL
]	NULL
and	NULL
LMO	NULL
also	NULL
express	NULL
RALDH2	NULL
.	NULL

A	NULL
T-ALL-specific	NULL
alternative	NULL
promoter	NULL
present	NULL
in	NULL
the	NULL
second	NULL
intron	NULL
of	NULL
the	NULL
RALDH2Z	NULL
gene	NULL
,	NULL
termed	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
,	NULL
was	NULL
transactivated	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
through	NULL
binding	NULL
of	NULL
a	NULL
TALI-LMO-GATA3	NULL
complex	NULL
to	NULL
a	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
RALDH2	NULL
gene	NULL
is	NULL
a	NULL
first	NULL
direct	NULL
downstream	NULL
gene	NULL
for	NULL
the	NULL
abberantly	NULL
activated	NULL
transcription	NULL
factors	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
.	NULL

Functional	NULL
synergy	NULL
between	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

Targeted	NULL
disruption	NULL
of	NULL
either	NULL
TAL	NULL
]	NULL
or	NULL
LMO2	NULL
resulted	NULL
in	NULL
embryonic	NULL
lethal-ity	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
yolk	NULL
sac	NULL
erythropoiesis	NULL
(	NULL
48	NULL
,	NULL
52	NULL
,	NULL
61	NULL
)	NULL
.	NULL

In	NULL
erythroid	NULL
cells	NULL
,	NULL
TAL1	NULL
and	NULL
LMO2	NULL
are	NULL
coexpressed	NULL
and	NULL
are	NULL
thought	NULL
to	NULL
regulate	NULL
erythropoiesis	NULL
by	NULL
forming	NULL
a	NULL
oligomeric	NULL
complex	NULL
with	NULL
GATA1	NULL
,	NULL
Ldb1	NULL
,	NULL
and	NULL
EZA	NULL
(	NULL
60	NULL
)	NULL
.	NULL

TAL1	NULL
and	NULL
LMO	NULL
are	NULL
also	NULL
synergistic	NULL
in	NULL
T-cell	NULL
tumorigenesis	NULL
in	NULL
double-transgenic	NULL
mice	NULL
(	NULL
2	NULL
,	NULL
30	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
a	NULL
complex	NULL
consisting	NULL
of	NULL
TAL1	NULL
and	NULL
LMO	NULL
also	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
T-cell	NULL
leukemia	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
both	NULL
TAL1	NULL
and	NULL
LMO	NULL
are	NULL
required	NULL
for	NULL
abberant	NULL
expression	NULL
of	NULL
RALDH2-T	NULL
in	NULL
T-ALL	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
RALDH2-T	NULL
in	NULL
the	NULL
development	NULL
of	NULL
T-ALL	NULL
is	NULL
unknown	NULL
(	NULL
see	NULL
below	NULL
)	NULL
,	NULL
complex	NULL
formation	NULL
between	NULL
TAL1	NULL
and	NULL
LMO	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
expression	NULL
of	NULL
target	NULL
genes	NULL
involved	NULL
in	NULL
tumorigenesis	NULL
.	NULL

The	NULL
roles	NULL
of	NULL
LMO1	NULL
and	NULL
LMO2	NULL
in	NULL
normal	NULL
development	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
different	NULL
,	NULL
since	NULL
these	NULL
genes	NULL
are	NULL
expressed	NULL
in	NULL
different	NULL
tissues	NULL
(	NULL
15	NULL
,	NULL
18	NULL
,	NULL
35	NULL
,	NULL
49	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
LMO2	NULL
but	NULL
not	NULL
LMOI	NULL
is	NULL
coexpressed	NULL
with	NULL
TAL	NULL
]	NULL
in	NULL
the	NULL
hematopoietic	NULL
lineage	NULL
(	NULL
56	NULL
)	NULL
.	NULL

The	NULL
structures	NULL
of	NULL
LMO1	NULL
and	NULL
LMO2	NULL
are	NULL
,	NULL
however	NULL
,	NULL
very	NULL
similar	NULL
,	NULL
and	NULL
both	NULL
are	NULL
capable	NULL
of	NULL
interacting	NULL
with	NULL
TAL1	NULL
and	NULL
GATA	NULL
proteins	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
(	NULL
42	NULL
,	NULL
56	NULL
,	NULL
59	NULL
)	NULL
.	NULL

Both	NULL
are	NULL
capable	NULL
of	NULL
inducing	NULL
RALDH2	NULL
in	NULL
collaboration	NULL
with	NULL
TAL1	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Previously	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
TAL	NULL
]	NULL
is	NULL
regularly	NULL
coexpressed	NULL
with	NULL
either	NULL
LMO1	NULL
or	NULL
LMO2	NULL
in	NULL
most	NULL
T-ALL	NULL
cell	NULL
lines	NULL
(	NULL
41	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
LMO1	NULL
and	NULL
LMO2	NULL
are	NULL
both	NULL
capable	NULL
of	NULL
playing	NULL
a	NULL
similar	NULL
role	NULL
in	NULL
T-ALL	NULL
oncogenesis	NULL
.	NULL

Since	NULL
target	NULL
genes	NULL
regulated	NULL
by	NULL
TAL1	NULL
and	NULL
LMO2	NULL
in	NULL
erythroid	NULL
cells	NULL
have	NULL
not	NULL
been	NULL
identified	NULL
,	NULL
their	NULL
transcriptional	NULL
activity	NULL
has	NULL
not	NULL
been	NULL
clarified	NULL
.	NULL

However	NULL
,	NULL
by	NULL
using	NULL
erythroid	NULL
pre-cursor-derived	NULL
cell	NULL
lines	NULL
,	NULL
TAL1	NULL
and	NULL
LMO2	NULL
were	NULL
both	NULL
shown	NULL
to	NULL
maintain	NULL
erythroid	NULL
cells	NULL
in	NULL
an	NULL
immature	NULL
state	NULL
and	NULL
promote	NULL
self-renewal	NULL
(	NULL
17	NULL
,	NULL
58	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
complex	NULL
of	NULL
TAL1	NULL
and	NULL
LMO	NULL
may	NULL
promote	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
growth	NULL
in	NULL
the	NULL
erythroid	NULL
cell	NULL
lineage	NULL
.	NULL

This	NULL
may	NULL
relate	NULL
closely	NULL
to	NULL
their	NULL
roles	NULL
in	NULL
T-cell	NULL
tumorigenesis	NULL
.	NULL

Mechanism	NULL
of	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
.	NULL

When	NULL
we	NULL
identified	NULL
RALDH2-T	NULL
as	NULL
a	NULL
target	NULL
gene	NULL
induced	NULL
by	NULL
TAL1	NULL
,	NULL
we	NULL
expected	NULL
that	NULL
an	NULL
E-box	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
RALDH2-T	NULL
was	NULL
an	NULL
important	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
results	NULL
obtained	NULL
by	NULL
transient-transfection	NULL
experiments	NULL
using	NULL
a	NULL
series	NULL
of	NULL
reporter	NULL
genes	NULL
with	NULL
deletions	NULL
and	NULL
point	NULL
mutations	NULL
clearly	NULL
demonstrated	NULL
that	NULL
a	NULL
GATA	NULL
site	NULL
at	NULL
position	NULL
-239	NULL
but	NULL
not	NULL
an	NULL
E-box	NULL
at	NULL
position	NULL
-273	NULL
was	NULL
necessary	NULL
for	NULL
the	NULL
induction	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
further	NULL
showed	NULL
that	NULL
GATA3	NULL
was	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
and	NULL
was	NULL
involved	NULL
in	NULL
the	NULL
transactivation	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
(	NULL
Fig	NULL
.	NULL

5E	NULL
and	NULL
F	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
activated	NULL
the	NULL
transcription	NULL
even	NULL
from	NULL
an	NULL
artificial	NULL
reporter	NULL
gene	NULL
linked	NULL
to	NULL
three	NULL
tandem	NULL
repeats	NULL
6948	NULL
ONO	NULL
ET	NULL
AL	NULL
.	NULL

Normal	NULL
T	NULL
cell	NULL
RALDH2-T	NULL
<	NULL
GaTaAs	NULL
>	NULL
X	NULL
GATA	NULL
site	NULL
Inr	NULL
T-ALL	NULL
ooo	NULL
Activate	NULL
RALDH2-T	NULL
I	NULL
»	NULL
GATA	NULL
site	NULL
Inr	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Model	NULL
of	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
by	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
.	NULL

In	NULL
normal	NULL
T	NULL
cells	NULL
,	NULL
GATA3	NULL
binds	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
but	NULL
does	NULL
not	NULL
activate	NULL
transcription	NULL
.	NULL

When	NULL
TAL1	NULL
and	NULL
LMO	NULL
are	NULL
ectopically	NULL
expressed	NULL
in	NULL
T-ALL	NULL
,	NULL
a	NULL
large	NULL
complex	NULL
containing	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
is	NULL
formed	NULL
on	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
a	NULL
downstream	NULL
initiator	NULL
(	NULL
Int	NULL
)	NULL
(	NULL
see	NULL
Discussion	NULL
)	NULL
.	NULL

of	NULL
the	NULL
GATA	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
GATA	NULL
site	NULL
alone	NULL
is	NULL
sufficient	NULL
for	NULL
transactivation	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GATA3	NULL
.	NULL

The	NULL
observations	NULL
that	NULL
the	NULL
TAL1-E47	NULL
heterodimer	NULL
did	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
and	NULL
that	NULL
TAL1B-BM	NULL
lacking	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
was	NULL
still	NULL
capable	NULL
of	NULL
inducing	NULL
RALDH2-T	NULL
like	NULL
the	NULL
wild-type	NULL
TAL1B	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMO	NULL
and	NULL
GATA3	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
to	NULL
F	NULL
)	NULL
further	NULL
indicate	NULL
that	NULL
the	NULL
direct	NULL
binding	NULL
of	NULL
TAL1	NULL
to	NULL
the	NULL
promoter	NULL
is	NULL
not	NULL
required	NULL
.	NULL

Together	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
LMO	NULL
family	NULL
proteins	NULL
are	NULL
thought	NULL
to	NULL
have	NULL
no	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
this	NULL
indicates	NULL
that	NULL
both	NULL
TAL1	NULL
and	NULL
LMO	NULL
appear	NULL
to	NULL
act	NULL
as	NULL
cofactors	NULL
for	NULL
GATA3	NULL
.	NULL

As	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
GATA3	NULL
is	NULL
likely	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
region	NULL
in	NULL
normal	NULL
T	NULL
cells	NULL
.	NULL

Importantly	NULL
,	NULL
however	NULL
,	NULL
GATA3	NULL
alone	NULL
does	NULL
not	NULL
activate	NULL
transcription	NULL
from	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

Only	NULL
when	NULL
TAL1	NULL
and	NULL
LMO	NULL
are	NULL
ectopically	NULL
coexpressed	NULL
in	NULL
T-ALL	NULL
,	NULL
a	NULL
large	NULL
transcriptional	NULL
complex	NULL
containing	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
that	NULL
is	NULL
capable	NULL
of	NULL
activating	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
is	NULL
formed	NULL
.	NULL

Thus	NULL
,	NULL
GATA3	NULL
may	NULL
act	NULL
as	NULL
a	NULL
DNA-binding	NULL
platform	NULL
for	NULL
LMO	NULL
and	NULL
TAL1	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Why	NULL
are	NULL
both	NULL
TAL1	NULL
and	NULL
LMO	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
RALDH2-T	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
?	NULL

LMO	NULL
can	NULL
interact	NULL
with	NULL
GATA3	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TAL1	NULL
in	NULL
vivo	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
,	NULL
but	NULL
expression	NULL
of	NULL
LMO	NULL
alone	NULL
in	NULL
HPB-ALL	NULL
cells	NULL
did	NULL
not	NULL
induce	NULL
transcription	NULL
from	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
LMO1	NULL
and	NULL
LMO2	NULL
contain	NULL
transactivation	NULL
domains	NULL
in	NULL
the	NULL
N	NULL
termini	NULL
(	NULL
32	NULL
,	NULL
50	NULL
)	NULL
,	NULL
LMO	NULL
itself	NULL
can	NULL
not	NULL
act	NULL
as	NULL
a	NULL
coactivator	NULL
for	NULL
GATA3	NULL
.	NULL

The	NULL
role	NULL
of	NULL
LMO	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
RALDH2-T	NULL
expression	NULL
may	NULL
be	NULL
to	NULL
bridge	NULL
TAL1	NULL
and	NULL
GATA3	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
.	NULL

Since	NULL
TAL1	NULL
does	NULL
not	NULL
interact	NULL
with	NULL
GATA3	NULL
directly	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
,	NULL
the	NULL
TAL1-E47	NULL
heterodimer	NULL
may	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
coactivator	NULL
for	NULL
GATA3	NULL
only	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMO	NULL
.	NULL

Various	NULL
transcription	NULL
factors	NULL
are	NULL
known	NULL
to	NULL
act	NULL
synergistically	NULL
with	NULL
GATA	NULL
family	NULL
proteins	NULL
.	NULL

For	NULL
example	NULL
,	NULL
SP1	NULL
and	NULL
EKLF	NULL
regulate	NULL
the	NULL
globin	NULL
gene	NULL
locus	NULL
control	NULL
region	NULL
with	NULL
GATA1	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
the	NULL
regulation	NULL
of	NULL
endothelin-1	NULL
gene	NULL
expression	NULL
in	NULL
en-dothelial	NULL
cells	NULL
,	NULL
GATAZ	NULL
and	NULL
AP1	NULL
act	NULL
cooperatively	NULL
(	NULL
26	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cases	NULL
,	NULL
GATA	NULL
family	NULL
proteins	NULL
and	NULL
other	NULL
factors	NULL
are	NULL
known	NULL
to	NULL
cooperate	NULL
by	NULL
binding	NULL
to	NULL
respective	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
regulatory	NULL
regions	NULL
.	NULL

However	NULL
,	NULL
when	NULL
one	NULL
of	NULL
these	NULL
sites	NULL
is	NULL
mutated	NULL
,	NULL
two	NULL
factors	NULL
are	NULL
still	NULL
capable	NULL
of	NULL
activating	NULL
transcription	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

through	NULL
the	NULL
remaining	NULL
site	NULL
.	NULL

In	NULL
other	NULL
words	NULL
,	NULL
one	NULL
factor	NULL
which	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
DNA	NULL
is	NULL
still	NULL
capable	NULL
of	NULL
collaborating	NULL
with	NULL
the	NULL
other	NULL
DNA-binding	NULL
factors	NULL
by	NULL
acting	NULL
as	NULL
a	NULL
cofactor	NULL
.	NULL

Similar	NULL
observations	NULL
have	NULL
been	NULL
reported	NULL
for	NULL
bHLH-type	NULL
transcription	NULL
factors	NULL
.	NULL

Myogenic	NULL
factor	NULL
MyoD	NULL
and	NULL
MADS	NULL
box	NULL
factor	NULL
MEF2	NULL
cooperatively	NULL
activate	NULL
transcription	NULL
through	NULL
each	NULL
binding	NULL
site	NULL
reciprocally	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
there	NULL
is	NULL
a	NULL
potential	NULL
E-box	NULL
besides	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Deletion	NULL
or	NULL
mutation	NULL
of	NULL
this	NULL
E-box	NULL
,	NULL
however	NULL
,	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
induction	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
existence	NULL
of	NULL
the	NULL
E-box	NULL
did	NULL
not	NULL
complement	NULL
the	NULL
mutation	NULL
in	NULL
the	NULL
GATA	NULL
site	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TAL1	NULL
and	NULL
LMO	NULL
,	NULL
GATA3CFM	NULL
lacking	NULL
DNA	NULL
binding	NULL
activity	NULL
could	NULL
not	NULL
transactivate	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

5E	NULL
and	NULL
F	NULL
)	NULL
,	NULL
whereas	NULL
a	NULL
similar	NULL
mutant	NULL
,	NULL
GATA1	NULL
disr.Cf	NULL
,	NULL
was	NULL
still	NULL
capable	NULL
of	NULL
acting	NULL
as	NULL
a	NULL
cofactor	NULL
for	NULL
SP1	NULL
in	NULL
the	NULL
globin	NULL
gene	NULL
enhancer	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
TAL1-LMO-GATA3	NULL
complex	NULL
could	NULL
not	NULL
activate	NULL
transcription	NULL
through	NULL
the	NULL
three	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
most	NULL
preferred	NULL
E-box	NULL
element	NULL
(	NULL
AACAGATGGT	NULL
)	NULL
linked	NULL
to	NULL
tk-lue	NULL
in	NULL
BALL-1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
other	NULL
cases	NULL
described	NULL
above	NULL
,	NULL
the	NULL
TAL1-LMO-GATA3	NULL
complex	NULL
activates	NULL
transcription	NULL
from	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
only	NULL
through	NULL
the	NULL
GATA	NULL
site	NULL
.	NULL

Why	NULL
does	NULL
GATA3	NULL
activate	NULL
RALDH2-T	NULL
transcription	NULL
only	NULL
by	NULL
forming	NULL
a	NULL
complex	NULL
with	NULL
TAL1	NULL
and	NULL
LMO	NULL
?	NULL

In	NULL
the	NULL
experiments	NULL
using	NULL
GATAX3-tk-lue	NULL
in	NULL
BALL-1	NULL
cells	NULL
,	NULL
only	NULL
sevenfold	NULL
activation	NULL
was	NULL
observed	NULL
even	NULL
though	NULL
three	NULL
tandem	NULL
repeats	NULL
of	NULL
the	NULL
element	NULL
were	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

This	NULL
may	NULL
suggest	NULL
that	NULL
other	NULL
cis-acting	NULL
elements	NULL
in	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
are	NULL
still	NULL
involved	NULL
in	NULL
full	NULL
induction	NULL
by	NULL
TAL1	NULL
,	NULL
LMO	NULL
,	NULL
and	NULL
GATA3	NULL
.	NULL

Preliminary	NULL
data	NULL
indeed	NULL
revealed	NULL
that	NULL
the	NULL
selective	NULL
deletion	NULL
of	NULL
the	NULL
50-bp	NULL
fragment	NULL
downstream	NULL
from	NULL
the	NULL
GATA	NULL
site	NULL
also	NULL
decreased	NULL
the	NULL
induction	NULL
of	NULL
RA4LDH2-T	NULL
as	NULL
did	NULL
the	NULL
GATA	NULL
site	NULL
mutation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
there	NULL
is	NULL
a	NULL
downstream	NULL
cis-acting	NULL
element	NULL
(	NULL
s	NULL
)	NULL
that	NULL
acts	NULL
synergistically	NULL
with	NULL
the	NULL
GATA	NULL
site	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
RALDH2-T	NULL
by	NULL
the	NULL
TAL1-LMO-GATA3	NULL
complex	NULL
.	NULL

TAL1	NULL
and	NULL
LMO	NULL
may	NULL
mediate	NULL
synergism	NULL
between	NULL
GATA3	NULL
and	NULL
an	NULL
unknown	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
that	NULL
binds	NULL
to	NULL
the	NULL
downstream	NULL
ele-ment	NULL
(	NULL
s	NULL
)	NULL
.	NULL

The	NULL
TAL1-LMO-GATA3	NULL
complex	NULL
in	NULL
T-ALL	NULL
may	NULL
contain	NULL
Ldb1	NULL
(	NULL
also	NULL
called	NULL
NL1	NULL
or	NULL
CLIM2	NULL
)	NULL
(	NULL
1	NULL
,	NULL
3	NULL
,	NULL
25	NULL
)	NULL
,	NULL
like	NULL
the	NULL
TAL1-LMO2-GATA1	NULL
complex	NULL
in	NULL
erythroid	NULL
cells	NULL
(	NULL
60	NULL
)	NULL
.	NULL

It	NULL
was	NULL
shown	NULL
that	NULL
Ldb1	NULL
was	NULL
required	NULL
for	NULL
synergistic	NULL
activation	NULL
of	NULL
the	NULL
«	NULL
GSU	NULL
promoter	NULL
by	NULL
P-Lim	NULL
and	NULL
P-Otx	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Ldb1	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
cooperation	NULL
between	NULL
the	NULL
TAL1-LMO-GATA3	NULL
complex	NULL
and	NULL
another	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
to	NULL
the	NULL
downstream	NULL
regions	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
in	NULL
T-ALL	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
Molt15	NULL
and	NULL
Molt17	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
TAL1	NULL
,	NULL
LMO2	NULL
,	NULL
and	NULL
GATA3	NULL
(	NULL
41	NULL
)	NULL
,	NULL
did	NULL
not	NULL
express	NULL
RALDH2-T	NULL
.	NULL

Since	NULL
these	NULL
cell	NULL
lines	NULL
strongly	NULL
express	NULL
TALLAI	NULL
(	NULL
54	NULL
)	NULL
,	NULL
which	NULL
is	NULL
also	NULL
apparently	NULL
induced	NULL
by	NULL
TAL1	NULL
and	NULL
LMO	NULL
in	NULL
T-ALL	NULL
(	NULL
41	NULL
)	NULL
,	NULL
TAL1	NULL
and	NULL
LMO2	NULL
are	NULL
likely	NULL
to	NULL
be	NULL
functional	NULL
in	NULL
these	NULL
cell	NULL
lines	NULL
.	NULL

This	NULL
also	NULL
suggests	NULL
that	NULL
some	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
other	NULL
than	NULL
GATA3	NULL
and	NULL
not	NULL
expressed	NULL
in	NULL
Molt15	NULL
and	NULL
Molt17	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
the	NULL
only	NULL
CD4~	NULL
CD8~	NULL
double-negative	NULL
lines	NULL
among	NULL
the	NULL
T-ALL	NULL
cell	NULL
lines	NULL
examined	NULL
(	NULL
54	NULL
)	NULL
,	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
transactivation	NULL
of	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
.	NULL

Further	NULL
studies	NULL
are	NULL
needed	NULL
to	NULL
elucidate	NULL
the	NULL
exact	NULL
mechanism	NULL
of	NULL
RALDH2-T	NULL
induction	NULL
in	NULL
T-ALL	NULL
.	NULL

Role	NULL
of	NULL
RALDH2-T	NULL
in	NULL
T-ALL	NULL
.	NULL

RALDH2	NULL
was	NULL
identified	NULL
as	NULL
an	NULL
enzyme	NULL
converting	NULL
retinal	NULL
to	NULL
retinoic	NULL
acid	NULL
(	NULL
63	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
RALDH2	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
trunk	NULL
region	NULL
of	NULL
the	NULL
developing	NULL
embryo	NULL
,	NULL
where	NULL
retinoic	NULL
acid	NULL
is	NULL
produced	NULL
(	NULL
63	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
retinoic	NULL
acid	NULL
inhibits	NULL
activation-induced	NULL
apoptosis	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
62	NULL
)	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
ectopically	NULL
expressed	NULL
RALDH2-T	NULL
inhibits	NULL
apoptosis	NULL
of	NULL
T	NULL
cells	NULL
by	NULL
generating	NULL
retinoic	NULL
acid	NULL
.	NULL

To	NULL
detect	NULL
retinoic	NULL
acid	NULL
in	NULL
T-ALL	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
transfected	NULL
Vou	NULL
.	NULL

18	NULL
,	NULL
1998	NULL
INDUCTION	NULL
OF	NULL
RALDH2	NULL
BY	NULL
TALl	NULL
AND	NULL
LMO	NULL
IN	NULL
T-ALL	NULL
_	NULL
6949	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
containing	NULL
a	NULL
retinoic	NULL
acid	NULL
response	NULL
element	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
retinal	NULL
as	NULL
a	NULL
substrate	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
reporter	NULL
was	NULL
not	NULL
observed	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

One	NULL
possibility	NULL
is	NULL
that	NULL
the	NULL
N-terminally	NULL
truncated	NULL
RALDH2-T	NULL
protein	NULL
may	NULL
not	NULL
have	NULL
the	NULL
enzymatic	NULL
activity	NULL
.	NULL

Alternatively	NULL
,	NULL
RALDH2-T	NULL
may	NULL
convert	NULL
another	NULL
substrate	NULL
or	NULL
act	NULL
as	NULL
a	NULL
dominant	NULL
negative	NULL
factor	NULL
for	NULL
other	NULL
enzymes	NULL
.	NULL

The	NULL
role	NULL
of	NULL
RALDH2-T	NULL
in	NULL
the	NULL
development	NULL
of	NULL
T-ALL	NULL
thus	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Besides	NULL
its	NULL
potential	NULL
role	NULL
in	NULL
T-ALL	NULL
,	NULL
RALDH2-T	NULL
may	NULL
also	NULL
provide	NULL
a	NULL
useful	NULL
marker	NULL
for	NULL
diagnosis	NULL
and	NULL
monitoring	NULL
of	NULL
T-ALL	NULL
,	NULL
since	NULL
this	NULL
type	NULL
of	NULL
RALDH2	NULL
transcript	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
in	NULL
normal	NULL
tissues	NULL
even	NULL
by	NULL
RT-PCR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
RALDH2-T	NULL
promoter	NULL
or	NULL
its	NULL
GATA	NULL
site	NULL
may	NULL
be	NULL
exploited	NULL
for	NULL
driving	NULL
gene	NULL
expression	NULL
specifically	NULL
in	NULL
T-ALL	NULL
for	NULL
therapeutic	NULL
purposes	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
K.	NULL
Maruyama	NULL
for	NULL
pMIKneo	NULL
and	NULL
pMIKhyg	NULL
,	NULL
Astar	NULL
Winoto	NULL
for	NULL
pc-KRR	NULL
,	NULL
Tetsuya	NULL
Yoshida	NULL
for	NULL
helpful	NULL
discussions	NULL
,	NULL
and	NULL
Yorio	NULL
Hinuma	NULL
and	NULL
Masakazu	NULL
Hatanaka	NULL
for	NULL
constant	NULL
support	NULL
and	NULL
encour-agement	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Agulnick	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
M.	NULL
Taira	NULL
,	NULL
J.	NULL
J.	NULL
Breen	NULL
,	NULL
T.	NULL
Tanaka	NULL
,	NULL
L	NULL
B.	NULL
Dawid	NULL
,	NULL
and	NULL
H.	NULL
Westphal	NULL
.	NULL

1996	NULL
.	NULL

Interactions	NULL
of	NULL
the	NULL
LIM-domain-binding	NULL
factor	NULL
Ldb1	NULL
with	NULL
LIM	NULL
homeodomain	NULL
proteins	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
384:270-272	NULL
.	NULL

2	NULL
.	NULL

Aplan	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
C.	NULL
A.	NULL
Jones	NULL
,	NULL
D.	NULL
S.	NULL
Chervinsky	NULL
,	NULL
X.	NULL
Zhao	NULL
,	NULL
M.	NULL
Ellsworth	NULL
,	NULL
C.	NULL
Wu	NULL
,	NULL
E.	NULL
A.	NULL
McGuire	NULL
,	NULL
and	NULL
K.	NULL
W.	NULL
Gross	NULL
.	NULL

1997	NULL
.	NULL

An	NULL
scl	NULL
gene	NULL
product	NULL
lacking	NULL
the	NULL
transactivation	NULL
domain	NULL
induces	NULL
bony	NULL
abnormalities	NULL
and	NULL
cooperates	NULL
with	NULL
LMO1	NULL
to	NULL
generate	NULL
T-cell	NULL
malignancies	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16	NULL
:	NULL
2408-2419	NULL
.	NULL

3	NULL
.	NULL

Bach	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Carriere	NULL
,	NULL
H.	NULL
P.	NULL
Ostendorff	NULL
,	NULL
B.	NULL
Andersen	NULL
,	NULL
and	NULL
M.	NULL
G.	NULL
Rosenfeld	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
family	NULL
of	NULL
LIM	NULL
domain-associated	NULL
cofactors	NULL
confer	NULL
transcriptional	NULL
synergism	NULL
between	NULL
LIM	NULL
and	NULL
Otx	NULL
homeodomain	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

11	NULL
:	NULL
1370-1380	NULL
.	NULL

4	NULL
.	NULL

Bash	NULL
,	NULL
R.	NULL
O.	NULL
,	NULL
S.	NULL
Hall	NULL
,	NULL
C.	NULL
F.	NULL
Timmons	NULL
,	NULL
W.	NULL
M.	NULL
Crist	NULL
,	NULL
M.	NULL
Amylon	NULL
,	NULL
R.	NULL
G.	NULL
Smith	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1995	NULL
.	NULL

Does	NULL
activation	NULL
of	NULL
the	NULL
TAL1	NULL
gene	NULL
occur	NULL
in	NULL
a	NULL
majority	NULL
of	NULL
patients	NULL
with	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
?	NULL

A	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
study	NULL
.	NULL

Blood	NULL
86:666-676	NULL
.	NULL

5	NULL
.	NULL

Begley	NULL
,	NULL
C.	NULL
G.	NULL
,	NULL
P.	NULL
D.	NULL
Aplan	NULL
,	NULL
S.	NULL
M.	NULL
Denning	NULL
,	NULL
B.	NULL
F.	NULL
Haynes	NULL
,	NULL
T.	NULL
A.	NULL
Waldmann	NULL
,	NULL
and	NULL
I.	NULL
R.	NULL
Kirsch	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
gene	NULL
SCL	NULL
is	NULL
expressed	NULL
during	NULL
early	NULL
hematopoiesis	NULL
and	NULL
encodes	NULL
a	NULL
differentiation-related	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:10128-10132	NULL
.	NULL

6	NULL
.	NULL

Bernard	NULL
,	NULL
O.	NULL
,	NULL
N.	NULL
Lecointe	NULL
,	NULL
P.	NULL
Jouveaux	NULL
,	NULL
M.	NULL
Souyri	NULL
,	NULL
M.	NULL
Mauchauffe	NULL
,	NULL
R.	NULL
Berger	NULL
,	NULL
C.	NULL
J.	NULL
Larsen	NULL
,	NULL
and	NULL
D.	NULL
Mathieu-Mahul	NULL
.	NULL

1991	NULL
.	NULL

Two	NULL
site-specific	NULL
deletions	NULL
and	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
restricted	NULL
to	NULL
human	NULL
T-cell	NULL
acute	NULL
leukemias	NULL
disrupt	NULL
the	NULL
5	NULL
'	NULL
part	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
.	NULL

Oncogene	NULL
6:1477-1488	NULL
.	NULL

7	NULL
.	NULL

Boehm	NULL
,	NULL
T.	NULL
,	NULL
L.	NULL
Foroni	NULL
,	NULL
Y.	NULL
Kaneko	NULL
,	NULL
M.	NULL
F.	NULL
Perutz	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbitts	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
rhombotin	NULL
family	NULL
of	NULL
cysteine-rich	NULL
LIM-domain	NULL
oncogenes	NULL
:	NULL
distinct	NULL
members	NULL
are	NULL
involved	NULL
in	NULL
T-cell	NULL
translocations	NULL
to	NULL
human	NULL
chromosomes	NULL
11p15	NULL
and	NULL
11p13	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:4367-4371	NULL
.	NULL

8	NULL
.	NULL

Brennan	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
T.	NULL
Chakraborty	NULL
,	NULL
and	NULL
E.	NULL
N.	NULL
Olson	NULL
.	NULL

1991	NULL
.	NULL

Mutagenesis	NULL
of	NULL
the	NULL
myogenin	NULL
basic	NULL
region	NULL
identifies	NULL
an	NULL
ancient	NULL
protein	NULL
motif	NULL
critical	NULL
for	NULL
activation	NULL
of	NULL
myogenesis	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:5675-5679	NULL
.	NULL

9	NULL
.	NULL

Carroll	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
W.	NULL
M.	NULL
Crist	NULL
,	NULL
M.	NULL
P.	NULL
Link	NULL
,	NULL
M.	NULL
D.	NULL
Amylon	NULL
,	NULL
D.	NULL
J.	NULL
Pullen	NULL
,	NULL
A.	NULL
H.	NULL
Ragab	NULL
,	NULL
G.	NULL
R.	NULL
Buchanan	NULL
,	NULL
R.	NULL
S.	NULL
Wimmer	NULL
,	NULL
and	NULL
T.	NULL
J.	NULL
Vietti	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p34	NULL
;	NULL
q11	NULL
)	NULL
is	NULL
nonrandom	NULL
and	NULL
restricted	NULL
to	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
:	NULL
a	NULL
Pediatric	NULL
Oncology	NULL
Group	NULL
study	NULL
.	NULL

Blood	NULL
76:1220-1224	NULL
.	NULL

10	NULL
.	NULL

Chen	NULL
,	NULL
Q.	NULL
,	NULL
J.	NULL
T.	NULL
Cheng	NULL
,	NULL
L.	NULL
H.	NULL
Tasi	NULL
,	NULL
N.	NULL
Schneider	NULL
,	NULL
G.	NULL
Buchanan	NULL
,	NULL
A.	NULL
Carroll	NULL
,	NULL
W.	NULL
Crist	NULL
,	NULL
B.	NULL
Ozanne	NULL
,	NULL
M.	NULL
J.	NULL
Siciliano	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
tal	NULL
gene	NULL
undergoes	NULL
chromosome	NULL
translocation	NULL
in	NULL
T	NULL
cell	NULL
leukemia	NULL
and	NULL
potentially	NULL
encodes	NULL
a	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:415-424	NULL
.	NULL

11	NULL
.	NULL

Davis	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
P.	NULL
F.	NULL
Cheng	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Lassar	NULL
,	NULL
and	NULL
H.	NULL
Weintraub	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
MyoD	NULL
DNA	NULL
binding	NULL
domain	NULL
contains	NULL
a	NULL
recognition	NULL
code	NULL
for	NULL
muscle-specific	NULL
gene	NULL
activation	NULL
.	NULL

Cell	NULL
60:733-746	NULL
.	NULL

12	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

13	NULL
.	NULL

Elwood	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
and	NULL
C.	NULL
G.	NULL
Begley	NULL
.	NULL

1995	NULL
.	NULL

Reconstitution	NULL
of	NULL
mice	NULL
with	NULL
bone	NULL
marrow	NULL
cells	NULL
expressing	NULL
the	NULL
SCL	NULL
gene	NULL
is	NULL
insufficient	NULL
to	NULL
cause	NULL
leukemia	NULL
.	NULL

Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

6:19-25	NULL
.	NULL

14	NULL
.	NULL

Finger	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
J.	NULL
Kagan	NULL
,	NULL
G.	NULL
Christopher	NULL
,	NULL
J.	NULL
Kurtzberg	NULL
,	NULL
M.	NULL
S.	NULL
Hershfield	NULL
,	NULL
P.	NULL
C.	NULL
Nowell	NULL
,	NULL
and	NULL
C.	NULL
M.	NULL
Croce	NULL
.	NULL

1989	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
TCLS	NULL
gene	NULL
on	NULL
human	NULL
chromosome	NULL
1	NULL
in	NULL
T-cell	NULL
leukemia	NULL
and	NULL
melanoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:5039-5043	NULL
.	NULL

15	NULL
.	NULL

Foroni	NULL
,	NULL
L.	NULL
,	NULL
T.	NULL
Boehm	NULL
,	NULL
L.	NULL
White	NULL
,	NULL
A.	NULL
Forster	NULL
,	NULL
P.	NULL
Sherrington	NULL
,	NULL
X	NULL
.	NULL

B.	NULL
Liao	NULL
,	NULL
C.	NULL
I	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

Brannan	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbitts	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
rhombotin	NULL
gene	NULL
family	NULL
encode	NULL
related	NULL
LIM-domain	NULL
proteins	NULL
whose	NULL
differing	NULL
expression	NULL
suggests	NULL
multiple	NULL
roles	NULL
in	NULL
mouse	NULL
development	NULL
.	NULL

J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

226	NULL
:	NULL
747-761	NULL
.	NULL

Fujiwara	NULL
,	NULL
Y.	NULL
,	NULL
C.	NULL
P.	NULL
Browne	NULL
,	NULL
K.	NULL
Cunniff	NULL
,	NULL
S.	NULL
C.	NULL
Goff	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1996	NULL
.	NULL

Arrested	NULL
development	NULL
of	NULL
embryonic	NULL
red	NULL
cell	NULL
precursors	NULL
in	NULL
mouse	NULL
embryos	NULL
lacking	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:12355-12358	NULL
.	NULL

Green	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
E.	NULL
DeLuca	NULL
,	NULL
and	NULL
C.	NULL
G.	NULL
Begley	NULL
.	NULL

1991	NULL
.	NULL

Antisense	NULL
SCL	NULL
suppresses	NULL
self-renewal	NULL
and	NULL
enhances	NULL
spontaneous	NULL
erythroid	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
leukaemic	NULL
cell	NULL
line	NULL
K562	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:4153-4158	NULL
.	NULL

Greenberg	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
T.	NULL
Bochm	NULL
,	NULL
M.	NULL
V.	NULL
Sofroniew	NULL
,	NULL
R.	NULL
J.	NULL
Keynes	NULL
,	NULL
S.	NULL
C.	NULL
Barton	NULL
,	NULL
M.	NULL
L.	NULL
Norris	NULL
,	NULL
M.	NULL
A.	NULL
Surani	NULL
,	NULL
M.	NULL
G.	NULL
Spillantini	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbits	NULL
.	NULL

1990	NULL
.	NULL

Segmental	NULL
and	NULL
developmental	NULL
regulation	NULL
of	NULL
a	NULL
presumptive	NULL
T-cell	NULL
oncogene	NULL
in	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
344:158-160	NULL
.	NULL

Ho	NULL
,	NULL
I.	NULL
C.	NULL
,	NULL
P.	NULL
Vorhees	NULL
,	NULL
N.	NULL
Marin	NULL
,	NULL
B.	NULL
K.	NULL
Oakley	NULL
,	NULL
S.	NULL
F.	NULL
Tsai	NULL
,	NULL
S.	NULL
H.	NULL
Orkin	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
GATA-3	NULL
:	NULL
a	NULL
lincage-restricted	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
alpha	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

10:1187-1192	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
J.	NULL
T.	NULL
Cheng	NULL
,	NULL
Q.	NULL
Chen	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
,	NULL
1991	NULL
.	NULL

Enhancer-binding	NULL
activity	NULL
of	NULL
the	NULL
Tal-1	NULL
oncoprotein	NULL
in	NULL
association	NULL
with	NULL
the	NULL
E47/E12	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:3037-3042	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
L.	NULL
Huang	NULL
,	NULL
J.	NULL
T.	NULL
Tsan	NULL
,	NULL
W.	NULL
Funk	NULL
,	NULL
W.	NULL
E.	NULL
Wright	NULL
,	NULL
J.	NULL
S.	NULL
Hu	NULL
,	NULL
R.	NULL
E.	NULL
Kingston	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1994	NULL
.	NULL

Preferred	NULL
sequences	NULL
for	NULL
DNA	NULL
recognition	NULL
by	NULL
the	NULL
TAL1	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1256-1265	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
I.	NULL
Wadman	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1994	NULL
.	NULL

Formation	NULL
of	NULL
in	NULL
vivo	NULL
complexes	NULL
between	NULL
the	NULL
TAL1	NULL
and	NULL
E2A	NULL
polypeptides	NULL
of	NULL
leukemic	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:3181-3185	NULL
.	NULL

Iwata	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Mukai	NULL
,	NULL
Y.	NULL
Nakai	NULL
,	NULL
and	NULL
R.	NULL
Iseki	NULL
.	NULL

1992	NULL
.	NULL

Retinoic	NULL
acids	NULL
inhibit	NULL
activation-induced	NULL
apoptosis	NULL
in	NULL
T	NULL
cell	NULL
hybridomas	NULL
and	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immu-nol	NULL
.	NULL

149:3302-3308	NULL
.	NULL

Javahery	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Khachi	NULL
,	NULL
K.	NULL
Lo	NULL
,	NULL
B.	NULL
Zenzie-Gregory	NULL
,	NULL
and	NULL
S.	NULL
T.	NULL
Smale	NULL
.	NULL

1994	NULL
.	NULL

DNA	NULL
sequence	NULL
requirements	NULL
for	NULL
transcriptional	NULL
initiator	NULL
activity	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:116-127.	NULL
.	NULL

Jurata	NULL
,	NULL
L.	NULL
W.	NULL
,	NULL
D.	NULL
A.	NULL
Kenny	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Gill	NULL
.	NULL

1996	NULL
.	NULL

Nuclear	NULL
LIM	NULL
interactor	NULL
,	NULL
a	NULL
rhombotin	NULL
and	NULL
LIM	NULL
homeodomain	NULL
interacting	NULL
protein	NULL
,	NULL
is	NULL
expressed	NULL
early	NULL
in	NULL
neuronal	NULL
development	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:11693-11698	NULL
.	NULL

Kawana	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
E.	NULL
Lee	NULL
,	NULL
E.	NULL
E.	NULL
Quertermous	NULL
,	NULL
and	NULL
T.	NULL
Quertermous	NULL
.	NULL

1995	NULL
.	NULL

Cooperative	NULL
interaction	NULL
of	NULL
GATA-2	NULL
and	NULL
AP1	NULL
regulates	NULL
transcription	NULL
of	NULL
the	NULL
endothelin-1	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:4225-4231	NULL
.	NULL

Kelliher	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
D.	NULL
C.	NULL
Seldin	NULL
,	NULL
and	NULL
P.	NULL
Leder	NULL
.	NULL

1996	NULL
.	NULL

Tal-1	NULL
induces	NULL
T	NULL
cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
accelerated	NULL
by	NULL
casein	NULL
kinase	NULL
Ho	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:5160-5166	NULL
.	NULL

Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
M.	NULL
Yamamoto	NULL
,	NULL
M.	NULL
W.	NULL
Leonard	NULL
,	NULL
K.	NULL
M.	NULL
George	NULL
,	NULL
P.	NULL
Ting	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Engel	NULL
.	NULL

1991	NULL
.	NULL

Murine	NULL
and	NULL
human	NULL
T-lymphocyte	NULL
GATA-3	NULL
factors	NULL
mediate	NULL
transcription	NULL
through	NULL
a	NULL
cis-regulatory	NULL
element	NULL
within	NULL
the	NULL
human	NULL
T-cell	NULL
receptor	NULL
delta	NULL
gene	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2778-2784	NULL
.	NULL

Ko	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Engel	NULL
.	NULL

1993	NULL
.	NULL

DNA-binding	NULL
specificities	NULL
of	NULL
the	NULL
GATA	NULL
transcription	NULL
factor	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:4011-4022	NULL
.	NULL

Larson	NULL
,	NULL
R.	NULL
C.	NULL
,	NULL
I.	NULL
Lavenir	NULL
,	NULL
T.	NULL
A.	NULL
Larson	NULL
,	NULL
R.	NULL
Baer	NULL
,	NULL
A.	NULL
J.	NULL
Warren	NULL
,	NULL
I	NULL
Wadman	NULL
,	NULL
K.	NULL
Nottage	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbits	NULL
.	NULL

1996	NULL
.	NULL

Protein	NULL
dimerization	NULL
between	NULL
Lmo2	NULL
(	NULL
Rbtn2	NULL
)	NULL
and	NULL
Tall	NULL
alters	NULL
thymocyte	NULL
development	NULL
and	NULL
potentiates	NULL
T	NULL
cell	NULL
tumorigenesis	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:1021-1027	NULL
.	NULL

Lefebvre	NULL
,	NULL
P.	NULL
,	NULL
M.	NULL
P.	NULL
Gaub	NULL
,	NULL
A.	NULL
Tabayato	NULL
,	NULL
C.	NULL
Rochette-Egly	NULL
,	NULL
and	NULL
P.	NULL
Form-stecher	NULL
.	NULL

1995	NULL
.	NULL

Protein	NULL
phosphatases	NULL
1	NULL
and	NULL
2A	NULL
regulate	NULL
the	NULL
transcriptional	NULL
and	NULL
DNA	NULL
binding	NULL
activities	NULL
of	NULL
retinoic	NULL
acid	NULL
receptors	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
10806-10816	NULL
.	NULL

Mao	NULL
,	NULL
S.	NULL
,	NULL
G.	NULL
A.	NULL
Neale	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Goorha	NULL
.	NULL

1997	NULL
.	NULL

T-cell	NULL
proto-oncogene	NULL
thom-botin-2	NULL
is	NULL
a	NULL
complex	NULL
transcription	NULL
regulator	NULL
containing	NULL
multiple	NULL
activation	NULL
and	NULL
repression	NULL
domains	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:5594-5599	NULL
.	NULL

Marine	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
A.	NULL
Winoto	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
human	NULL
enhancer-binding	NULL
protein	NULL
Gata3	NULL
binds	NULL
to	NULL
several	NULL
T-cell	NULL
receptor	NULL
regulatory	NULL
elements	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:7284-7288	NULL
.	NULL

McGuire	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
R.	NULL
D.	NULL
Hockett	NULL
,	NULL
K.	NULL
M.	NULL
Pollock	NULL
,	NULL
M.	NULL
F.	NULL
Bartholdi	NULL
,	NULL
S.	NULL
J.	NULL
O'Brien	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
t	NULL
(	NULL
11	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p15	NULL
;	NULL
q11	NULL
)	NULL
in	NULL
a	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
cell	NULL
line	NULL
activates	NULL
multiple	NULL
transcripts	NULL
,	NULL
including	NULL
#	NULL
ig-1	NULL
,	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
potential	NULL
zinc	NULL
finger	NULL
protein	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:2124-2132	NULL
.	NULL

McGuire	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
A.	NULL
R.	NULL
Davis	NULL
,	NULL
and	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
.	NULL

1991	NULL
.	NULL

T-cell	NULL
translocation	NULL
gene	NULL
1	NULL
(	NULL
Tig-1	NULL
)	NULL
encodes	NULL
a	NULL
nuclear	NULL
protein	NULL
normally	NULL
expressed	NULL
in	NULL
neural	NULL
lineage	NULL
cells	NULL
.	NULL

Blood	NULL
77:599-606	NULL
.	NULL

McKnight	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
E.	NULL
R.	NULL
Gavis	NULL
,	NULL
R.	NULL
Kingsbury	NULL
,	NULL
and	NULL
R.	NULL
Axel	NULL
.	NULL

1981	NULL
.	NULL

Analysis	NULL
of	NULL
transcriptional	NULL
regulatory	NULL
signals	NULL
of	NULL
the	NULL
HSV	NULL
thymidine	NULL
kinase	NULL
gene	NULL
:	NULL
identification	NULL
of	NULL
an	NULL
upstream	NULL
control	NULL
region	NULL
.	NULL

Cell	NULL
25:385-398	NULL
.	NULL

Merika	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1993	NULL
.	NULL

DNA-binding	NULL
specificity	NULL
of	NULL
GATA	NULL
family	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:3999-4010	NULL
.	NULL

Merika	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
synergy	NULL
and	NULL
physical	NULL
interactions	NULL
of	NULL
the	NULL
erythroid	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
with	NULL
the	NULL
Kruppel	NULL
family	NULL
proteins	NULL
Sp1	NULL
and	NULL
EKLF	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2437-2447	NULL
.	NULL

Molkentin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
B.	NULL
L.	NULL
Black	NULL
,	NULL
J.	NULL
F.	NULL
Martin	NULL
,	NULL
and	NULL
E.	NULL
N.	NULL
Olson	NULL
.	NULL

1995	NULL
.	NULL

Cooperative	NULL
activation	NULL
of	NULL
muscle	NULL
gene	NULL
expression	NULL
by	NULL
MEF2	NULL
and	NULL
myogenic	NULL
bHLH	NULL
proteins	NULL
.	NULL

Cell	NULL
83:1125-1136	NULL
.	NULL

Murre	NULL
,	NULL
C.	NULL
,	NULL
P.	NULL
S.	NULL
McCaw	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1989	NULL
.	NULL

A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
6950	NULL
41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

ONO	NULL
ET	NULL
AL	NULL
.	NULL

dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
,	NULL
and	NULL
myc	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777-783	NULL
.	NULL

Ono	NULL
,	NULL
Y.	NULL
,	NULL
N.	NULL
Fukuhara	NULL
,	NULL
and	NULL
O.	NULL
Yoshie	NULL
.	NULL

1997	NULL
.	NULL

Transcriptional	NULL
activity	NULL
of	NULL
TAL1	NULL
in	NULL
T	NULL
cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
T-ALL	NULL
)	NULL
requires	NULL
RBTN1	NULL
or	NULL
-2	NULL
and	NULL
induces	NULL
TALLA1	NULL
,	NULL
a	NULL
highly	NULL
specific	NULL
tumor	NULL
marker	NULL
of	NULL
T-ALL	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:4576-4581	NULL
.	NULL

Osada	NULL
,	NULL
H.	NULL
,	NULL
G.	NULL
Grutz	NULL
,	NULL
H.	NULL
Axelson	NULL
,	NULL
A.	NULL
Forster	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbits	NULL
.	NULL

1995	NULL
.	NULL

Association	NULL
of	NULL
erythroid	NULL
transcription	NULL
factors	NULL
:	NULL
complexes	NULL
involving	NULL
the	NULL
LIM	NULL
protein	NULL
RBTN2	NULL
and	NULL
the	NULL
zinc-finger	NULL
protein	NULL
GATAL	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:9585-9589	NULL
.	NULL

Pevay	NULL
,	NULL
L.	NULL
,	NULL
M.	NULL
C.	NULL
Simon	NULL
,	NULL
E.	NULL
Robertson	NULL
,	NULL
W.	NULL
H.	NULL
Klein	NULL
,	NULL
S.	NULL
F.	NULL
Tsai	NULL
,	NULL
V.	NULL
D'Agati	NULL
,	NULL
S.	NULL
H.	NULL
Orkin	NULL
,	NULL
and	NULL
F.	NULL
Costantini	NULL
.	NULL

1991	NULL
.	NULL

Erythroid	NULL
differentiation	NULL
in	NULL
chimacric	NULL
mice	NULL
blocked	NULL
by	NULL
a	NULL
targeted	NULL
mutation	NULL
in	NULL
the	NULL
gene	NULL
for	NULL
transcription	NULL
factor	NULL
GATA-1	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
349:257-260	NULL
.	NULL

Pulford	NULL
,	NULL
K.	NULL
,	NULL
N.	NULL
Lecointe	NULL
,	NULL
K.	NULL
Leroy-Viard	NULL
,	NULL
M.	NULL
Jones	NULL
,	NULL
D.	NULL
Mathieu-Mahul	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Mason	NULL
.	NULL

1995	NULL
.	NULL

Expression	NULL
of	NULL
TAL-1	NULL
proteins	NULL
in	NULL
human	NULL
tissues	NULL
.	NULL

Blood	NULL
85:675-684	NULL
.	NULL

Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
Boehm	NULL
.	NULL

1990	NULL
.	NULL

LIM	NULL
domains	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
346	NULL
:	NULL
418	NULL
.	NULL

Rabbitts	NULL
,	NULL
T.	NULL
H.	NULL
1994	NULL
.	NULL

Chromosomal	NULL
translocations	NULL
in	NULL
human	NULL
cancer	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
372:143-149	NULL
.	NULL

Robb	NULL
,	NULL
L.	NULL
,	NULL
J.	NULL
E.	NULL
Rasko	NULL
,	NULL
M.	NULL
L.	NULL
Bath	NULL
,	NULL
A.	NULL
Strasser	NULL
,	NULL
and	NULL
C.	NULL
G.	NULL
Begley	NULL
.	NULL

1995.	NULL
scl	NULL
,	NULL
a	NULL
gene	NULL
frequently	NULL
activated	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukaemia	NULL
,	NULL
does	NULL
not	NULL
induce	NULL
lymphomas	NULL
in	NULL
transgenic	NULL
mice	NULL
.	NULL

Oncogene	NULL
10:205-209	NULL
.	NULL

Robb	NULL
,	NULL
L.	NULL
,	NULL
I	NULL
Lyons	NULL
,	NULL
R.	NULL
Li	NULL
,	NULL
L.	NULL
Hartley	NULL
,	NULL
F.	NULL
Kontgen	NULL
,	NULL
R.	NULL
P.	NULL
Harvey	NULL
,	NULL
D.	NULL
Metcalf	NULL
,	NULL
and	NULL
C.	NULL
G.	NULL
Begley	NULL
.	NULL

1995	NULL
.	NULL

Absence	NULL
of	NULL
yolk	NULL
sac	NULL
hematopoiesis	NULL
from	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
the	NULL
sel	NULL
gene	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7075-7079	NULL
.	NULL

Royer-Pokora	NULL
,	NULL
B.	NULL
,	NULL
U.	NULL
Loos	NULL
,	NULL
and	NULL
W.	NULL
D.	NULL
Ludwig	NULL
.	NULL

1991	NULL
.	NULL

TTG-2	NULL
,	NULL
a	NULL
new	NULL
gene	NULL
encoding	NULL
a	NULL
cysteine-rich	NULL
protein	NULL
with	NULL
the	NULL
LIM	NULL
motif	NULL
,	NULL
is	NULL
overexpressed	NULL
in	NULL
acute	NULL
T-cell	NULL
leukaemia	NULL
with	NULL
the	NULL
t	NULL
(	NULL
11	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p13	NULL
;	NULL
q11	NULL
)	NULL
.	NULL

Oncogene	NULL
6:1887-1893	NULL
.	NULL

Sanchez-Garcia	NULL
,	NULL
I.	NULL
,	NULL
H.	NULL
Axelson	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbitts	NULL
.	NULL

1995	NULL
.	NULL

Functional	NULL
diversity	NULL
of	NULL
LIM	NULL
proteins	NULL
:	NULL
amino-terminal	NULL
activation	NULL
domains	NULL
in	NULL
the	NULL
oncogenic	NULL
proteins	NULL
RBTN1	NULL
and	NULL
RBTN2	NULL
.	NULL

Oncogene	NULL
10:1301-1306	NULL
.	NULL

Schmeichel	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Beckerle	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
LIM	NULL
domain	NULL
is	NULL
a	NULL
modular	NULL
protein-binding	NULL
interface	NULL
.	NULL

Cell	NULL
79:211-219	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
E.	NULL
L.	NULL
Mayer	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1995	NULL
.	NULL

Absence	NULL
of	NULL
blood	NULL
formation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
T-cell	NULL
leukaemia	NULL
oncoprotein	NULL
tal-1/SCL	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
373:432-434	NULL
.	NULL

Smith	NULL
,	NULL
V.	NULL
M.	NULL
,	NULL
P.	NULL
P.	NULL
Lee	NULL
,	NULL
S.	NULL
Szychowski	NULL
,	NULL
and	NULL
A.	NULL
Winoto	NULL
.	NULL

1995	NULL
.	NULL

GATA-3	NULL
dominant	NULL
negative	NULL
mutant	NULL
.	NULL

Functional	NULL
redundancy	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

alpha	NULL
and	NULL
beta	NULL
enhancers	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:1515-1520	NULL
.	NULL

Takagi	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Fujikawa	NULL
,	NULL
T.	NULL
Imai	NULL
,	NULL
N.	NULL
Fukuhara	NULL
,	NULL
K.	NULL
Fukudome	NULL
,	NULL
M.	NULL
Minegishi	NULL
,	NULL
S.	NULL
Tsuchiya	NULL
,	NULL
T.	NULL
Konno	NULL
,	NULL
Y.	NULL
Hinuma	NULL
,	NULL
and	NULL
O.	NULL
Yoshie	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
highly	NULL
specific	NULL
surface	NULL
marker	NULL
of	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
and	NULL
neuroblastoma	NULL
as	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
transmembrane	NULL
4	NULL
superfamily	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
61:706-715	NULL
.	NULL

Tsai	NULL
,	NULL
S.	NULL
F.	NULL
,	NULL
D.	NULL
I.	NULL
Martin	NULL
,	NULL
L.	NULL
I.	NULL
Zon	NULL
,	NULL
A.	NULL
D.	NULL
D'Andrea	NULL
,	NULL
G.	NULL
G.	NULL
Wong	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1989	NULL
.	NULL

Cloning	NULL
of	NULL
cDNA	NULL
for	NULL
the	NULL
major	NULL
DNA-binding	NULL
protein	NULL
of	NULL
the	NULL
erythroid	NULL
lineage	NULL
through	NULL
expression	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
339:446-451	NULL
.	NULL

Valge-Archer	NULL
,	NULL
V.	NULL
E.	NULL
,	NULL
H.	NULL
Osada	NULL
,	NULL
A.	NULL
J.	NULL
Warren	NULL
,	NULL
A.	NULL
Forster	NULL
,	NULL
J.	NULL
Li	NULL
,	NULL
R.	NULL
Baer	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbitts	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
LIM	NULL
protein	NULL
RBTN2	NULL
and	NULL
the	NULL
basic	NULL
helix-loop-helix	NULL
protein	NULL
TAL1	NULL
are	NULL
present	NULL
in	NULL
a	NULL
complex	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:8617-8621	NULL
.	NULL

Visvader	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
G.	NULL
Begley	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Adams	NULL
.	NULL

1991	NULL
.	NULL

Differential	NULL
expression	NULL
of	NULL
the	NULL
LYL	NULL
,	NULL
SCL	NULL
and	NULL
E2A	NULL
helix-loop-helix	NULL
genes	NULL
within	NULL
the	NULL
hemopoietic	NULL
system	NULL
.	NULL

Oncogene	NULL
6:187-194	NULL
.	NULL

Visvader	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
X.	NULL
Mao	NULL
,	NULL
Y.	NULL
Fujiwara	NULL
,	NULL
K.	NULL
Hahm	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Orkin	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
LIM-domain	NULL
binding	NULL
protein	NULL
Ldb1	NULL
and	NULL
its	NULL
partner	NULL
LMO2	NULL
act	NULL
as	NULL
negative	NULL
regulators	NULL
of	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:13707-13712	NULL
.	NULL

Wadman	NULL
,	NULL
I.	NULL
,	NULL
J.	NULL
Li	NULL
,	NULL
R.	NULL
O.	NULL
Bash	NULL
,	NULL
A.	NULL
Forster	NULL
,	NULL
H.	NULL
Osada	NULL
,	NULL
T.	NULL
H.	NULL
Rabbits	NULL
,	NULL
and	NULL
R.	NULL
Baer	NULL
.	NULL

1994	NULL
.	NULL

Specific	NULL
in	NULL
vivo	NULL
association	NULL
between	NULL
the	NULL
bHLH	NULL
and	NULL
LIM	NULL
proteins	NULL
implicated	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:4831-4839	NULL
.	NULL

Wadman	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
,	NULL
H.	NULL
Osada	NULL
,	NULL
G.	NULL
G.	NULL
Grutz	NULL
,	NULL
A.	NULL
D.	NULL
Agulnick	NULL
,	NULL
H.	NULL
Westphal	NULL
,	NULL
A.	NULL
Forster	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbitts	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
LIM-only	NULL
protein	NULL
Lmo2	NULL
is	NULL
a	NULL
bridging	NULL
molecule	NULL
assembling	NULL
an	NULL
erythroid	NULL
,	NULL
DNA-binding	NULL
complex	NULL
which	NULL
includes	NULL
the	NULL
TAL1	NULL
,	NULL
E47	NULL
,	NULL
GATA-1	NULL
and	NULL
Ldb1/NLI	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

16:3145-3157	NULL
.	NULL

Warren	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
W.	NULL
H.	NULL
Colledge	NULL
,	NULL
M.	NULL
B.	NULL
Carlton	NULL
,	NULL
M.	NULL
J.	NULL
Evans	NULL
,	NULL
A.	NULL
J.	NULL
Smith	NULL
,	NULL
and	NULL
T.	NULL
H.	NULL
Rabbitts	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
oncogenic	NULL
cysteine-rich	NULL
LIM	NULL
domain	NULL
protein	NULL
rbtn2	NULL
is	NULL
essential	NULL
for	NULL
erythroid	NULL
development	NULL
.	NULL

Cell	NULL
78:45-57	NULL
.	NULL

Yang	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
S.	NULL
Vacchio	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Ashwell	NULL
.	NULL

1993	NULL
.	NULL

9-cis-retinoic	NULL
acid	NULL
inhibits	NULL
activation-driven	NULL
T-cell	NULL
apoptosis	NULL
:	NULL
implications	NULL
for	NULL
retinoid	NULL
X	NULL
receptor	NULL
involvement	NULL
in	NULL
thymocyte	NULL
development	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:6170-6174	NULL
.	NULL

Zhao	NULL
,	NULL
D.	NULL
,	NULL
P.	NULL
McCaffery	NULL
,	NULL
K.	NULL
J.	NULL
Ivins	NULL
,	NULL
R.	NULL
L.	NULL
Neve	NULL
,	NULL
P.	NULL
Hogan	NULL
,	NULL
W.	NULL
W.	NULL
Chin	NULL
,	NULL
and	NULL
U.	NULL
C.	NULL
Drager	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
identification	NULL
of	NULL
a	NULL
major	NULL
retinoic-acid-synthe-sizing	NULL
enzyme	NULL
,	NULL
a	NULL
retinaldehyde-specific	NULL
dehydrogenase	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

240	NULL
:	NULL
15-22	NULL
.	NULL

